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Abstract 
GABA-A RECEPTOR SUBUNIT ALTERATIONS FOLLOWING EXPERIMENTAL 
TRAUMATIC BRAIN INJURY AND THE EFFECTS OF AN NMDA 
ANTAGONIST: A WESTERN BLOT ANALYSIS 
Cynthia J .  Gibson, Master of  Science 
A dissertation submitted in partial fulfi llment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2001 
Major Director: Robert J .  Hamm, Ph .D . ,  Department of Psychology 
Traumatic brain injury (TBI)  produces an acute phase of neuronal 
excitation followed by a chronic phase of depressed neuronal function. 
Alterations in eXCitatory and inhibitory receptor interactions may be dynamically 
involved in subsequent long-term detriments in neuronal and cognitive 
functioning. TBI- induced elevations in intracellular calcium concentrations 
([Ca2+D are mediated primarily by the NMDA receptor. Elevated [Ca2+]; may 
trigger intracellular mechanisms which drive changes in GABA-A receptor protein 
synthesis and expression,  ultimately resulting in receptor dysfunction. 
Western blot analysis was used to investigate alterations to GABA-A 
receptor subunits a 1  and �3 in the hippocampus of rats 3 hours, 24 hours, or 7 
xiii 
days following TBI .  No injury- induced alterations in protein expression were 
found for the 133 subunit, which in the hippocampus is primarily located on 
principal neurons ( i .e. ,  pyramidal and granule cells) . No significant alterations to 
the 0 1  receptor were found 3 hours following TBI , but a sign ificant increase in 
01 protein was found 24 hours post- injury, and this increase persisted for at 
least 7 days. GABA-A receptors contain ing the 0 1  subunit are primarily located 
on interneurons, implying a potential strengthening of interneuron-mediated 
inhibitory tone during the chronic phase of TBI .  
Study 2 used pre-injury injections of MK-801 (0.3 mg/kg) to block calcium 
influx through the NMDA receptor. This treatment normalized 0 1  protein 
expression 24 hours following injury (the time point of greatest change in study 
1 ) . NMDA-mediated calcium influx may, therefore, be responsible for triggering 
the cascade that results in increased GABA-A receptor 01 protein expression 
chronically following TBI .  
These studies demonstrate that TBI produces an increase in GABA-A 
receptor 0 1 ,  but not 133, subunits 24 hours and 7 days post-injury. The 
differential directions of the subunit changes may ind icate a strengthening of 
inhibitory tone during the chronic phase of TBI ,  a period characterized by a 
depression of neuronal function .  Although the exact mechanism of change to the 
a1 subunit is unknown, study 2 indicates that it is driven by NMDA-mediated 
elevations in [Ca2+]; . The functional consequences of increased inhibitory tone 
may contribute to long-term detriments in cognitive and behavioral outcome 
following injury. 
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I ncidence and Causes 
Introduction 
Traumatic Brain Injury 
Traumatic brain injury (TBI)  is the leading cause of death in people less 
than 40 years of age (Zauner & Bullock, 1 998). Each year in the U .S . ,  
approximately 1 .5 mill ion people sustain a TB I ,  resulting in  50,000 deaths, 
230,000 hospitalizations, and nearly 90,000 new cases of long-term disability. 
TBI is the leading cause of death and permanent disability among children and 
young adults. Currently, 5 .3  million Americans (2% of the population) are living 
with TBI-related deficits, although this may be a low estimate (Center for Disease 
Control, 1 999). 
The incidence of TBI clearly demonstrates its importance as a public 
health problem. Because of its low visibility and high incidence, TBI has been 
referred to as the "invisible epidemic" (CDC, 1 999), costing Americans 
approximately 37.8 bill ion dollars per year (Max, MacKenzie, & Rice, 1 99 1 ) . The 
risk of TBI is substantial across all age groups, with peak incidences among 
adolescents, young adults, and the elderly (75 years or older) . 
Although the incidence of TBI due to motor vehicle crashes has declined 
by 38% over the last two decades, transportation-related accidents sti ll account 
for 49% of all TBI hospitalizations. Firearm violence accounts for only 1 0% of all 
TBls, an 1 1  % increase since 1 980, yet firearms have been the leading cause of 
TBI-related death since 1 990 (CDC, 1 999). Falls are the leading cause of TBI 
among the elderly (CDC, 1 999; Harrison-Felix et a I . ,  1 996). 
Injury Severity 
Although there are some discrepancies in TBI severity classifications, on 
average 60% of injuries are mild , 20% are moderate and 20% are severe 
(Frankowski, 1 986). The Glasgow Coma Scale (GCS) is the most accepted 
2 
rating scale for measuring injury severity. Mild injury is generally classified as a 
GCS score of 1 3- 1 5, moderate injury is represented by a score of 9-1 2  and 
severe injury receives a score of 3-8. These are general categories and do not 
represent a strict definition. Because so many variables are involved , and the 
GCS score is subject to each doctor's interpretation, there is much controversy in 
the literature regarding the reliabil ity of the scale. Factors contributing to the GCS 
score include eye, verbal and motor reactions. Also taken into account are length 
of unconsciousness, duration of amnesia or confusion, surgical requirements 
(such as removing blood clots), secondary insults such as seizures or ischemia, 
skull fractures and computerized tomography (CT) scan results (Colohan & 
Oyesiku, 1 992). Mild, moderate, and severe injuries have varied pathologies and 
neuropsychological consequences. 
Mild injuries generally do not include a period of unconsciousness, yet the 
average cost of treatment is $44 ,014 (Lehmkuhl ,  Hall ,  Mann, & Gordon, 1 993). 
Cognitive impairments following mild head injury have not received much 
3 
attention because the deficits may be subtle. Many patients complain of post­
concussive symptoms such as d izziness, headache, nausea, and confusion. The 
cognitive areas least affected by a mild injury include overall intelligence, 
language, perceptual and motor functions. The most prevail ing cognitive deficits 
include problems with memory, attention,  and information processing. 
Information processing problems typically diminish within three months of injury, 
whereas memory problems are not always noticeable during the first three 
months following injury. Most cognitive impairments diminish gradually over the 
course of the first year post-injury (Packard, Weaver, & Ham, 1 993). Memory, 
attention and information processing deficits are likely to have an impact on the 
patient's lifestyle and job performance abil ity. 
Moderate TBI results in an average of five days of unconsciousness and a 
mean treatment cost of $85,682 (Lehmkuhl et a I . ,  1 993). The outcome from 
moderate TBI varies widely. GCS scores of nine or ten have a 7-9% mortality 
rate and a much slower recovery compared to GCS scores of 1 1  or 12 ,  which 
rarely result in death and are often moved to the mild category within 24 hours.  
Failure to return to work is estimated at 69%, a substantial increase over the 
estimated 34% for mild injuries (Rimel, Giordani, Barth, & Jane, 1 982). Moderate 
injury often results in more impairment than mild injury, with 49% retaining a 
moderate disabil ity, 1 0% a severe disability, and a 3% mortality rate from injury­
related complications. This leaves only 38% who are classified as 'good 
recovery.'  Memory problems, which affect 90% of moderate injury patients, are 
the primary reason for unemployment. Predominating impairments tend to be in 
areas related to higher-level cognitive skills such as problem-solving, attention, 
visual reaction times, and memory for auditory and visual tasks. Overall 
intelligence does not seem to be greatly affected .  The location and size of brain 
lesion resulting from the injury are related to the type and severity of the 
impairments (Colohan & Oyesiku, 1 992). 
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Severe TBI is represented by 1 2-34 days of unconsciousness, with an 
average cost between $1 1 1 , 000 and $1 54,000 (Lehmkuhl et a I . ,  1 993). Severe 
head injury is more complicated and life-threatening than either mild or moderate 
injury. In  one study of severely injured patients, 68% died during their hospital 
stay, 1 3.3% died shortly after discharge, and 6. 1 % remained in a vegetative 
state six months later. Only 1 2 .5% were classified as functional survivors. Older 
patients ( 1 00% of those over 50) were the most likely to die. Functional recovery 
was only seen in patients less than 30 years of age. Low GCS scores and 
abnormal pupil responses were strong indicators of mortality (Quigley et a I . ,  
1 997). Functional survivors of  severe head injury are likely to face a lifetime of 
neuropsychological and physical disabilities. Only 3% return to comparable 
employment levels (Wehman et aI . , 1 993). 
The Costs of TBI 
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The monetary costs of TBI are staggering. The U .S .  spends more than 
$37.8 bill ion per year in direct and ind irect TBI-related expenses (Max, 
MacKenzie, & Rice, 1 99 1 ). Accord ing to a 1 999 report to Congress, TBI 
accounts for one third of all injury-related mortality (CDC, 1 999). Fatal cases 
(6.3%) account for 84% of the total ,  includ ing funeral costs and loss of revenue 
(Grabow, Offord , & Reider, 1 984). Gunshots ($1 64,250) and motorcycle crashes 
($1 65,294) account for the highest mean charges, while assaults ($89,940) 
account for the lowest charges (Lehmkuhl et a I . ,  1 993). 
In 1 995, the average acute care cost was approximately $1 05,800 and the 
average rehabil itative care was $58,400 (Harrison-Felix et aI . , 1 998). A large 
portion of these costs are paid for by public funds. In 1 992, military hospitals paid 
almost 42 million dollars for TBI-related injuries, the median cost per patient 
being $35,400 (Ommaya et a I . ,  1 996). Estimates indicate that 29-3 1 %  of acute 
care and 31 -39% of rehabil itative care are paid for by Medicare or Medicaid 
(Harrison-Felix et ai, 1 996; Lehmkuhl et a I . ,  1 993). Further costs to the public 
include loss of employment. Approximately 39% of those employed at the time of 
injury are unable to return to work one year later (Harrison-Felix et a I . ,  1996). 
The indirect costs of TBI are likely to have the greatest impact on patients' 
lives. They include short term intellectual ,  motor, and learning impairments and 
long term rehabilitation, revenue loss, and intellectual limitations in the areas of 
memory and concentration. 
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I njury Pathology 
Types of Injuries 
The mechanism of injury determines the resulting pathology. There are 
two main types of brain injuries. First, injuries are classified as either penetrating 
or non-penetrating. A penetrating injury, from a bullet or other object, may cause 
tissue destruction, brain lacerations and hemorrhage. Non-penetrating injuries 
usually result from blunt impact of the brain with the inside of the skull. These 
closed head injuries are known as acceleration-deceleration and may occur 
either linearly or rotationally within the skull. The second major injury type refers 
to focal or diffuse injuries. A focal injury is l imited to a specific region of the brain, 
resulting in contusion, laceration, hemorrhage, and/or infarction. Focal injuries 
may result from penetrating or non-penetrating blows to the head . The frontal 
and temporal lobes are especially vulnerable to focal injuries. Diffuse injury may 
also include axonal injury and secondary loss due to hypoxia or ischemia. 
Secondary insults often result from increased intracranial pressure ( ICP) or 
cardiovascular collapse following a closed head injury. Diffuse injuries typically 
lead to specific patterns of necrosis in the cortex and infarctions of the 
hippocampus and basal ganglia (Selzer, 1 995). 
Primary and Secondary I njuries 
Primary brain injury occurs at the moment of impact. The initial 
mechanical insult produces primary damage, including surface contusion and 
laceration, d iffuse axonal injury (OAI) and intracranial hemorrhage. Primary 
(mechanical) damage affects blood vessels, axons, neurons and glia and may 
represent a focal, multi-focal or d iffuse pattern of injury. OAI, focal contusions 
and intracranial hematomas due to hemorrhage provide the potential for 
secondary damage such as ischemia, hypoxia, cerebral swelling/edema, 
increased ICP, hypotension, and seizures (Alessandri & Bullock, 1 998). 
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Primary methods of injury include contact of the skull with a foreign object 
or unrestricted head movement due to acceleration-deceleration forces of the 
brain within the skul l .  Contact injuries primarily result from falls and result in focal 
damage such as local or regional lesions, skull fracture, surface contusions and 
intracranial hemorrhage. Acceleration-deceleration injuries primarily result from 
motor vehicle crashes and produce diffuse types of injuries. Shear, tensile and 
compressive strains often occur due to diffuse injuries and may result in subdural 
hematomas (SOH) and widespread axonal damage (Mcintosh et aI., 1 996). 
Secondary damage involves changes that are initialized at the time of 
impact. The biochemical cascade of events that follows involves changes leading 
to neuronal damage. Neuronal cell body injury in the gray matter occurs in 
stages. Neurons in direct contact with an object or the skull d ie immediately and 
form a core of primary damage. Membrane ionic balance is d isrupted in 
damaged neurons, which release excessive excitatory amino acids (EAA), 
resulting in further depolarization and calcium entry into nearby neurons. 
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Further complicating the injury potential, delayed secondary damage may 
be more severe than the initial loss. Secondary damage may include ischemia, 
swelling (edema), and alterations of normal neurochemical functions and 
mechanisms. Secondary damage may not present clinically for hours or even 
days, providing a potential window for intervention. Recovery begins with 
neurons that may have been damaged but not killed (Selzer, 1 995). Primary and 
secondary consequences of TBI are summarized in Table 1 .  
The Excitotoxicity Hypothesis 
Glutamate, the most widely distributed excitatory neurotransmitter 
(NT) in the brain, is toxic at high concentrations. High levels ( 1 0  to 200 IJM) are 
released into the extra-cellular fluid (ECF) following injury (Alessandri & Bullock, 
1 998). The excitotoxicity hypothesis, as it relates to TBI ,  postulates that 
activation of muscarinic cholinergic and/or N-methyl-D-aspartate (NMDA) type 
glutamate receptors occurs due to excessive TBI-induced neuronal 
depolarization and subsequent neurotransmitter (NT) release. This over­
excitation then contributes to resulting TBI pathophysiology (Hayes, Jenkins, & 
Lyeth, 1 992b). Glutamatergic receptor antagonists administered before injury 
have been shown to reduce histological, functional and behavioral 
Table 1 .  TBI-induced primary and secondary damage 
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1 0  
Types of Primary and Secondary Damage 
Type of Injury Type of Damage 
Laceration (cuts) Primary 
Contusion (bruising) Primary 
Disturbed ion gradients Primary 
Edema (swelling) Primary I Secondary 
Hematoma (due to hemorrhage) Secondary 
Ischemia (decreased blood flow) Secondary 
Hypoxia (decreased oxygen) Secondary 
Diffuse Axonal Injury (DAI) Secondary (Primary at membrane) 
II 
consequences in animal models of TBI (Alessandri & Bullock, 1 998). 
Neurochemical alterations following TBI are related to excitotoxic processes and 
abnormal agonist-receptor interactions. Treatment potential lies in the possibil ity 
that neurochemical processes which mediate brain pathophysiology associated 
with TBI may respond to pharmacological therapies (Hayes, Jenkins, & Lyeth, 
1 992b). 
Experimental Models of TBI 
The Biomechanics of Experimental Brain Injury 
Valid TBI models mimic the mechanical forces, causes, and 
consequences which occur in human patients. The mechanical loading forces 
include impact forces and inertial (acceleration) forces. Brief (usually < 50 msec) 
mechanical deformation results in brain injury. The type and extent of brain injury 
are dependent on the location,  magnitude and direction of the loading forces. 
The most common mechanical causes of TBI are due to impact loading 
forces. Impact loading refers to direct contact between the head and a solid 
object. These contact effects result in local deformation of the skull, overall brain 
movement within the skull, and potentially devastating tissue strain to the 
underlying neuronal tissue. Inertial loading refers to ind irect head movements 
resulting from an impact to other areas of the body. I nertial acceleration effects 
produce an overall pressure distortion and neuronal tissue strain which results in 
primary tissue damage (Mcintosh et aI . , 1 996) . 
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Contact Effects due to Impact 
Impact loading forces may result in skull fracture due to focally distributed 
forces. Local skull depression produces distinctive stress zones caused by 
waves of d istortion radiating from the point of impact. These waves disperse and 
meet at various places within the skull. causing additive pressure and potential 
skull fracture in areas remote from the impact site. Local skull distortion may also 
occur without overt fracture. The amount of local skull d isplacement is an 
ind ication of the pressure and distortion experienced by underlying tissue and 
the tissue affected by stress waves radiating from the point of contact. 
Impact forces produce contact effects such as skull bending. intracranial 
pressure ( ICP). and focal lesions due to contusions. lacerations and hematomas. 
An intracranial hematoma is often considered a more extensive form of 
contusion and a subdural hematoma is due to vascular damage underlying the 
impact site. Epidural hematoma is more likely caused by torn vessels due to 
fracture (85%) than to ICP (1 5%) (Mcintosh et al.. 1 996). 
Inertial (Acceleration) Effects 
Inertial acceleration of the brain within the skull produces a separate type 
of injury with different mechanical effects. There are two primary types of inertial 
effects: translational acceleration (acceleration-deceleration movement along a 
straight path) and rotational acceleration (brain rotation within the skull). 
Translational acceleration produces movement of the brain within the skull and 
1 3  
increased ICP. The magnitude of peak ICP is directly due to the level of 
translational acceleration. Rotational acceleration produces widespread tissue 
strain within the brain and the shear strain is directly related to the level of 
rotational acceleration, direction of motion, and potential intracranial impact with 
dural compartments such as the tentorium cerebri (Mcintosh et a I . ,  1 996). 
Assumptions and Hypotheses in Animal Modeling 
Animal models rely on the hypothesis that human injury can be dupl icated 
in nonhumans. Some assumptions must be made in order to al low generalization 
from a model to human conditions. Species differences are assumed to be of 
minimal consequence, and the injury production mechanism is a means by which 
to model the resulting sequella. The injury mechanism in humans takes on 
greater importance due to safety measure development and prevention. 
There are several important aspects of injury that should be represented 
in a good animal model, including the location of brain damage, the type of 
damage produced, the severity and time course of injury, and long term and 
short term alterations. The model should also be able to effectively assess 
changes in morphology, cerebrovascular processes, metabolic receptors, and 
behavior (Gennarell i ,  1 994). 
Acceleration Concussion and Percussion Concussion 
Two categories of injury were distinguished by Denny-Brown and Russell 
in 1 941 :  acceleration concussion and percussion concussion. Acceleration 
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concussion i s  modeled primarily by inertial injury models. These models produce 
acceleration without impact or with diffuse loading and have been used in 
primates, cats, and swine. Another acceleration concussion model is impact 
acceleration, which is also referred to as the weight drop model. Impact 
acceleration involves an impactor such as a piston or weight, which is dropped 
directly onto the skull or onto a steel plate covering the skull. The latter 
minimizes local ized skull loading and fracture. This model has been 
demonstrated effectively in primates, cats, and rats (Gennarell i ,  1 994) .  
Fluid percussion injury (FPI)  i s  a widely used model of  percussion 
concussion. This model was used in cats until 1 987, when it was modified for 
use in rats due to their compatibil ity with behavioral tasks. The central ,  lateral ,  or 
lateral with contralateral dura opening variations of the model have also been 
used in dog, rabbit, and swine. In this model , a small fluid volume is injected into 
subdural or supradural space. Impact is provided via a fluid column or rapid 
pump infusion. 
Another model of percussion concussion is rigid indentation, also known 
as controlled cortical impact (CCI). In this model, a piston strikes the brain 
directly through a large craniotomy hole. Impact is controlled at about 2 to 3 
m/sec and penetrates 2 to 3 mm deep. Variations of this model include central, 
lateral, or lateral with contralateral open dura injuries. 
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Other models of injury that have very specific usefulness include injection 
models, where a small amount of fluid or blood is injected into epidural ,  subdural, 
or intracerebral brain locations. Local tensile models produce injury under 
pressure or suction of the open dura (Gennarelli, 1 994). 
The most frequently used animal models of TBI include central or lateral 
FPI ,  central or lateral CCI, weight drop , and injection models (for subdural 
hematoma injuries). Areas of particular interest to the excitotoxicity hypothesis of 
injury include: DAI ,  contusion, fracture, acute subdural ,  epidural ,  or intracerebral 
hematoma ,  and brain swelling (Alessandri & Bullock, 1 998). Animal models have 
done well in their attempts to model morphological changes following TBI but 
areas that are less well characterized include: neurological changes in the areas 
of cognition, memory and long-term outcome; physiology, as in cerebral 
metabolism; and biochemistry, such as gene expression and ionic changes 
(Gennarelli , 1 994). 
Models of Excitotoxicity 
Models that involve glutamate infusion have been shown to activate all 
glutamate receptor subtypes. Glutamate is then removed from the synapse by 
astrocytes. Other excitotoxic infusions such as kainic acid (KA), N-methyl-D­
aspartate (NMDA), or a-amin-3-hydroxy-5 methyl-4 isoxazale proponic acid 
(AMPA) do not have this synaptic removal property (Alessandri & Bullock, 1 998). 
Excitotoxicity of glutamate has been demonstrated to produce hypermetabolism, 
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which is neuro-protected with NMDA and AMPAlKainate (AM PAlKA} receptor 
antagonists such as D-CPPene, MK-801 ,  and NBQX, as well as with the free 
radical and lipid peroxidase inhibitors 174006F and D-amphetamine (Fujisawa, 
Landolt, & Bullock, 1 996; Hovda et a I . ,  1 995; Sutton, Hovda, Chen, & Feeney, 
2000). These in-vivo models of excitotoxicity provide support for the potential 
damage of excessive glutamatergic activity. Glutamate infusion damages cortical 
tissue synergistically following FPI ,  likely due to the increased vulnerabil ity of 
neurons to glutamate following injury (Bullock & Di, 1 997). Although glutamate is 
the best characterized excitotoxin ,  acetylcholine (ACh) and kainic acid (KA) also 
have excitotoxic properties that have been demonstrated both in vitro and in vivo 
(Regan & Choi, 1 991 ) .  The concentrations needed to kill cortical neurons are 
lowest for NMDA, then AMPA, and kainic acid , respectively. The strongest 
excitotoxic effects are produced by glutamate (Regan, 1 996). 
Models of Focal and Diffuse TBI 
Physical, computer and cell culture models have all contributed to the 
understanding of specific aspects of head injury. However, animate models are 
the only true representations of the complex changes that occur within a living 
organism in response to brain trauma. Two distinctions have been made in 
model type: focal and diffuse (Mcintosh et a I . ,  1 996) .  Each of these types of 
injuries has their own sequence of changes and cascades of events, some of 
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which are similar and some of which are distinctively different (see Table 2 for a 
complete summary). 
Focal injury models describe the pathology concerning contact effects 
from impact forces. Cortical contusion is common to focal injuries and has been 
well-characterized in rats (Dixon et a I . ,  1 987; Dixon, Glifton ,  Lighthall , Yaghamai, 
& Hayes, 1 99 1 ;  Feeney, Boyeson, Linn, Murray, & Dail ,  1 981 ; Mcintosh et a I . ,  
1 989; Nilsson,  Ponten, & Voight, 1 977; Shapira et a I . ,  1 988; Toulmond, Duval ,  
Serrano, Scatton,  & Benavides, 1 993), mice,  cats, ferrets, pigs, and other 
primates (Lighthall ,  1 988; Lindgren & Rinder, 1 965; Ommaya, Hirsch , & Flamm, 
1 966; Smith et a I . ,  1 995; Sul livan et a I . ,  1 976) . Primary skull displacement lasting 
approximately 1 0-30 msec occurs due to contact (focal) loading forces (Mcintosh 
et a I . ,  1 996). TBI with contusion may be analogous to ischemic focal forebrain 
infarction (Hayes, Jenkins & Lyeth, 1 992b). TBI models that produce cortical 
contusion may also cause damage to areas remote from the injury site (Mcintosh 
et aI. , 1 996). 
Several models are available that can produce a focal injury (see Table 
2), including impact acceleration (weight drop) (Feeney et ai, 1 981 ; Mcintosh et 
aI . , 1 989; Ni lsson, Ponten, & Voight, 1 977), fluid percussion (Dixon et a I . ,  1987; 
Lindgren & Rinder, 1 965; Mcintosh et a I . ,  1 989; Toulmond et a I . ,  1 993), and rigid 
indentation (CCI) (Dixon et aI . , 1 991 ; Soares, Thomas, Cloherty, & Mcintosh, 
1 992; Smith et a I . ,  1 995). A common feature of each of these models is that the 
Table 2.  The injury characteristics of commonly used animal models of TBI 
1 8  
1 9  
Injury Characteristics of TBI Animal Models 
Animal Model Focall Diffuse Injury Uses- Injury Type Species Studied 
Cortical weight drop! Focal Contusion rat 
Impact Acceleration Neuronal loss 
Potential seizures 
Impaired motor ability 
Cortical impact (CCI) Focal Contusion rat, ferret 
Axonal damage 
Fluid Percussion (FP) Both Lateral and Behavioral dysfunction rat, cat, micropig, 
Central effects: Brief coma non-human 
Impaired motor ability primates 
Axonal injury 
Vascular abnormalities 
Neurochemical changes 
Possible contusion 
Focal (Lateral) Neuronal cell loss 
Unilateral damage 
Diffuse (Central) Brain stem involvement 
Bilateral damage 
Inertial injury Diffuse Full spectrum of human micropigs and 
head injury, morbidity, non-human 
and coma primates 
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head is held steady in one position as the injury occurs (Mcintosh et aI . ,  1 996). 
The weight drop model often produces contusion at the injury site, neuronal loss 
of the hippocampi, thalamus and brain stem nuclei, and may produce skull 
fracture, prolonged coma, DAI and seizures (Beaumont et aI . ,  1 999; Foda & 
Marmarou, 1 994; Gennarell i ,  1 994; Marmarou et a I . ,  1 994; Povlishock, Hayes, 
Michel & Mcintosh, 1 994). The rigid indentation model (CCI )  normally produces a 
focal contusion at the injury site, axonal damage, and lower mortal ity due to 
reduced brain stem damage, compared to the cortical weight drop model 
(Povlishock et aI . , 1 994). Central CCI produces unconsciousness, contusion to 
the parasagital cortex under the impact site and non-d iffuse axonal damage. 
Lateral CCI injuries produce a brief coma, a small amount of diffuse axonal 
damage and contusion at impact site (Gennarell i ,  1 994). 
In the FPI model, fluid is injected through a sealed cannula-type hub into 
the closed cranium. This model has been well characterized . It has been 
associated with behavioral detriments, transient coma, impaired motor function ,  
and altered learning and memory (Povlishock et  a I . ,  1 994). Structural 
abnormalities have been noted , includ ing subarachnoid hemorrhage and axonal 
injury. Cell loss in the cortices and hippocampi is common in moderate severity 
injuries, with contusion likely at higher severities, especially in lateral injuries 
(Gennarelli, 1 994). Cerebral vascular abnormalities in blood flow and blood-brain 
barrier (BBB) permeability, neurochemical changes controlling ionic 
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homeostasis, and metabolic alterations have also been documented (Povlishock 
et aI . , 1 994). For focal injuries, the lateral FP model is preferable, with the central 
FP model producing a more diffuse type of injury (Gennarelli , 1 994; Povlishock 
et a I . ,  1 994). 
Lateral FPI is more likely to result in focal contusion . Cortical changes are 
often un ilateral to the side of injury, sparing the contralateral cortex and brain 
stem. Ipsilateral changes in white matter axons and occasional deep tissue tears 
at gray-white matter junctions may occur. Unilateral hippocampal damage has 
been well characterized (Gennarell i ,  1 994) .  
Central FP I  i s  less likely to produce contusion and overt cell loss at  the 
impact site. Bilateral cortical responses and brain stem involvement (including 
axonal injury) are common features of the central FPI model (Gennarell i ,  1 994; 
Mcintosh et aI . , 1 996, Povlishock et a I . ,  1 994) .  FPI ,  however, provides only 
limited biomechanical control and does not represent the ful l  spectrum of human 
TBI (e.g. , prolonged unconsciousness) . H igher severity levels of injury are often 
complicated by brain stem involvement and rats are more susceptible to the 
confound of pulmonary edema (Povlishock et a I . ,  1 994). Diffuse TBI-induced 
depolarization without contusion has similar neuropathological consequences as 
diffuse forebrain ischemia, resulting in selective neuronal deficits without overt 
cell loss (Hayes, Jenkins & Lyeth, 1 992b). 
Species Selection in Animal Modeling 
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The choice of  species in  TBI modeling is  important. There may be 
different patterns and distributions of receptors between humans and various 
other species. This must be weighed against the societal and financial expenses 
involved in using phylogenetically closer species. Rodent animal models, 
particularly rats, have been well-characterized and have the benefit of provid ing 
extensive normative data. Their small size and availability permits exhaustive 
structural and functional studies to be performed (Povlishock et a I . ,  1 994). Their 
age, genetic background , and environment can all be controlled to reduce 
experimental variability, and their high infection resistence and compatibility with 
neurochemical and neuropharmacological techniques have made them a 
popular choice in animal models. Central FPI in rats has been shown to be 
reliable at mild to moderate levels, without the complications of focal tissue 
damage (Dixon et aI . ,  1 987). 
Important similarities between humans and rodents include impact 
depolarization and a high correlation between rodents' receptor pharmacology 
and neurochemical changes and humans' TBI-induced behavioral deficits 
(Hayes, Jenkins & Lyeth, 1 992b). Rodents' physiologic responses may differ 
from humans, however, and they do not provide complete modeling of complex 
human changes due to their smaller neocortex and their lack of complex gyri and 
sulci (Povlishock et aI . ,  1 994). 
Parallels Between Experimental Fluid Percussion Injury and Human TBI 
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The pressure forces recorded from human cadaver skulls upon impact are 
similar to the forces modeled by experimental FPI  (Lindgren & Rinder, 1 966) . 
Acute neurological symptoms and suppression of behavioral reflexes mimic 
human unconsciousness/coma (Teasdale, 1 976). Dixon et al .  characterized the 
FPI model in rats in 1 987, using neurological and histopathological endpoints 
following various injury severity levels. Acute neurological evaluations indicated 
that mortality was positively correlated with injury severity, with an average 
mortality for moderate injury around 30-35%. A primary cause of mortality was 
pulmonary edema, which was not significantly correlated with injury severity. 
Convulsions were only seen at higher injury levels (>2 . 1  ATM) and a positive 
correlation was found between injury magnitude and apneic episodes 
(respiration cessation and resumption >1 0 sec). Acute somatomotor responses 
were developed to be similar to human reflexes on which GCS scores are based . 
Somatomotor nonpostural responses correlated to injury magnitude included 
corneal and pinna reflexes. Somatomotor postural responses, also correlated to 
injury magnitude, included paw flexion ,  tail flexion,  startle reflex, and righting 
reflex. Sham animals were normal within one minute of removal from the injury 
device. Systemic cardiovascular variables included : increased mean arterial 
blood pressure (MABP), which peaked within 1 0  sec and was not graded by 
injury severity level; brief bradycardia (5- 1 0  sec), with the heart rates of all injury 
levels lowered to 50% of baseline, and decreases in p02 and pC02 at high 
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severity levels on ly. Plasma glucose increased at 5 min for a l l  injury groups and 
pulmonary edema ("pink fulminating exudate") increased carbon dioxide, lowered 
oxygen and produced 1 00% mortality. Most of the measures documented in this 
study (and others) show similarities to moderate human head injury, as 
measured by the GCS (Dixon et a I . ,  1 991 ) .  
The Hippocampus 
The hippocampus resides within the temporal lobe and is one of several 
brain structures that are selectively vulnerable to TBI .  The hippocampal 
formation is an elongated, C-shaped structure that wraps around the 
diencephalon from the septal nuclei of the forebrain to the temporal lobe. The 
hippocampal formation consists of four primary structures: the dentate gyrus 
(DG), the entorhinal cortex (EC), the hippocampus proper, and the subicular 
complex. The hippocampus proper is further divided into CA 1 ,  CA2 and CA3 
regions. The structures of the hippocampus have a distinctive laminar 
orientation. Although most of the hippocampal connections are feed forward, 
GABAergic interneurons also provide feedback information to the original 
structure. The EC provides the major hippocampal input via the perforant 
pathway, terminating primarily in the DG. The DG projects mossy fibers to the 
CA3 fold of the hippocampus proper, which in turn projects to the CA 1 region. 
The subiculum receives the primary output from the hippocampus proper. 
Hippocampal structures communicate ipsilaterally via associational projections 
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and by commissural projections to the contralateral structures (Amaral & Witter, 
1 995) (See Figure 1 ) . 
Subsectors of the Hippocampal Formation 
Entorhinal Cortex 
Information from cortical structures such as the perirhinal cortex, the 
tetrosplenial cortex and the medial frontal cortex are relayed to the hippocampus 
via the EC. Feed-forward projections from the EC innervate the DG and the CA 1 
and CA3 regions of the hippocampus. The EC receives feedback information 
from the CA 1 and from the subiculum. Projections from the EC to the 
hippocampal regions are collectively referred to as the perforant pathway. The 
perforant pathway consists of projections from many EC cell types, including 
stellate, pyramidal, GABAergic, and others (Amaral & Witter, 1 995). 
The EC has two main subdivisions: the lateral entorhinal area (LEA) and 
the medial entorhinal area (MEA) (Amaral & Witter, 1 995). The primary perforant 
pathway projections are to the outer two-thirds of the molecular layer of the DG, 
where terminals synapse on dendritic spines of granule cells. There are also 
some synapses on GABAergic interneurons. The LEA projects to the outer one­
third of the molecular layer of the DG and the MEA projects to the middle one­
third of the DG (Hjorth-Simonsen, 1 972; Nafstad ,  1 967; Steward, 1 976; Witter, 
1 993; Wyss, 1 981 ) .  The inner one-third of the DG receives mossy cell 
projections from the polymorphic layer (Amaral & Witter, 1 995). The perforant 
Figure 1 .  A diagram of a coronal section of the mid-dorsal hippocampal 
formation of the rat. The primary connective pathways are shown: Schaffer 
collaterals (S), mossy fibers (M), and the perforant pathway (P). The 
hippocampus proper is subdivided into CA 1 ,  CA2, and CA3 regions and the 
dentate gyrus (OG) is also shown. 
Key: SO = stratum oriens 
SP = stratum pyramidal (pyramidal cell layer) 
SR = stratum radiatum 
SLM = stratum lacunosum moleculare 
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pathway also has some feed-forward projections to the CA 1 and CA3 regions of 
the hippocampus proper, although only the CA 1 reciprocates these projections 
(Amaral & Witter, 1 995; Nafstad , 1 967; Steward & Scoville, 1 976). 
Dentate Gyrus 
The laminar structure of the DG consists of the molecular layer, the 
granule cell layer, and the polymorphic layer. The molecular layer primarily 
contains apical dendrites of granule cells as well as some smaller stellate cell 
bodies. The granule cell layer, consists primarily of granule cell bodies, although 
GABAergic basket cells are found nestled between the granule and polymorphic 
layers (Amaral & Witter, 1 995). There is approximately one basket cell to every 
1 80 granule cells (Amaral ,  Ishizuka, & Claiborne, 1 990). The polymorphic layer, 
commonly referred to as the hilus, contains mossy cells as well as basal 
dendrites and axonal projections of granule cells. 
Although relatively cell-free, the molecular layer does contain some 
basket cells and axo-axonic interneurons known as chandelier cells (Amaral & 
Witter, 1 995). These interneurons are primarily GABAergic, providing pre­
synaptic input to the perforant pathway and synaptic input to dendrites of the 
granule cells in the granule cell layer. GABAergic chandelier cells may contribute 
to regulation of granule cell excitatory input from the EC (Somogyi et a I . ,  1 985; 
Soriano & Fotscher, 1 989). 
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The granule cell layer consists primarily of granule cell somata which 
extend their axons to the CA3 region.  The stratum lucid urn layer, found only in 
the CA3 region of the hippocampus, consists of mossy fiber projections from the 
granule cells of the DG. Mossy fibers bend temporally, forming an "end bulb," 
which demarcates the CA3 and CA2 regions of the hippocampus. Besides axo­
axonic feedback from interneurons, granule cells also receive synaptic input from 
basket cells, which are also primarily GABAergic. Because of the wrapped 
orientation of the hippocampus, the molecular and granule cell layer meet and 
form a 'V' shape. The suprapyramidal blade refers to the layered portion closest 
to the CA 1 and the infrapyramidal blade is furthest from the CA 1 .  Between the 
blades of this region, basal to the granule cell layer, is the polymorphic layer 
(Amaral & Witter, 1 995). 
Mossy cells are the most common cell type in the polymorphic cell layer. 
Mossy cells have large triangular or multipolar shaped bodies with proximal 
dendrites covered in spines or "thorny excrescences", which are termination sites 
of mossy fiber axons (Ribak, Seress, & Amaral ,  1 985; Frotscher, Seress, 
Schwerdtfeger, & Buhl ,  1 99 1 ) .  These spines are also seen in proximal dendrites 
of CA3 pyramidal cells. Primarily glutamatergic, mossy cell projections may form 
as many as 37 synapses with a single CA3 pyramidal cell dendrite (Amaral & 
Witter, 1 995; Chicurel & Harris, 1 992). 
Hippocampus Proper 
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The hippocampus proper consists of CA 1 ,  CA2, and CA3 regions. CA2 
and CA3 areas contain primarily large pyramidal cells, whereas pyramidal cells 
of the CA 1 are noticeably smaller. The narrow CA2 differs in poorly 
characterized connectional and functional ways from CA 1 and CA3 regions. The 
border of CA2 and CA3 is marked by the termination of the stratum lucidum. 
H ippocampal laminar organization is similar in al l  areas of the 
hippocampus proper. The pyramidal cell layer is the main cellular layer. Basal 
dendrites extend into the stratum oriens (SO) layer. Apical dendritic trees extend 
through the stratum radiatum (SR) and stratum lacunosum-moleculare (SLM) 
layers. The SR layer receives input from CA3 to CA 1 Schaffer collaterals. CA3 to 
CA3 associational (ipsilateral) and commissural (contralateral) terminals are also 
located in the SR layer. Some EC perforant pathway fibers travel and terminate 
in the SLM layer of the CA 1 ,  although the majority of perforant pathway input is 
to the DG (Amaral & Witter, 1 995). 
Although not well characterized, there are a variety of primarily GABAergic 
local interneurons located throughout the layers of the hippocampus proper. The 
pyramidal cell layer consists primarily of pyramidal cells but GABAergic basket 
cells are also present, located along the SP/ SO border (Seress & Ribak, 1 984) .  
These basket cells are the most common type of  interneuron in the CA 1 .  Basket 
cells of the SP/ SO border directly inhibit pyramidal cells in this region 
(Thompson, 1 994). The dendrites of the basket cells appear beaded and have 
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few dendritic spines. I n  contrast to the basket cells at the SPI SO border, the 
interneurons at the SRI SLM border do not receive CA 1 input. These 
interneurons terminate on the distal dendrites of the SO layer in the CA 1 (Amaral 
& Witter, 1 995). I nterneurons of the DG and CA3 receive direct input from septal 
projections (Amaral & Witter, 1 995; Freund & Antal ,  1 988). CA3 interconnections 
to both CA3 and CA 1 are divergent and extensive. As many as 6000 CA3 
neurons ( 1 .9% of the CA3 cell population) may innervate a single other CA3 
neuron.  Also, a single CA 1 neuron may be innervated by as many as 5500 CA3 
neurons ( 1 .8% of the CA3 cell population) . CA3 projections may, therefore, play 
important roles in h ippocampal inter-communication (Amaral, Ishizuka, & 
Claiborne, 1 990). 
Subiculum 
The primary output from the hippocampus proper originates in the CA 1 
and is relayed to the subiculum. The subiculum projects to the EC and also has 
minor projections to other cortical areas, includ ing the limbic cortex, the nucleus 
accumbens and the lateral septal region. The aforementioned cortical 
connections to the subiculum in turn project to the hypothalamus and the 
amygdala. The SR layer is not as prominent in the subiculum and the SO and 
molecular layers widen to accommodate the enlarged pyramidal cells (Amaral & 
Witter, 1 995). 
Histopathological Changes to the Hippocampus Following FPI 
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The hippocampus is known to be vulnerable to ischemia, seizures and 
brain trauma. Cognitive deficits, some of which are mediated by the 
hippocampus, are the most common long-term consequence of TBI in human 
patients (Mcintosh et a I . ,  1 996). Unlike ischemia, which produces damage in the 
CA 1 region, lateral TBI results in damage primarily in the CA3 and the hilus of 
the DG. Focal models often result in cell loss in these areas (Cortez, Mcintosh, & 
Noble, 1 989; H icks, Smith , Lowenstein , SaintMarie, & Mcintosh, 1 993; Soares, 
Hicks, Smith, & Mcintosh, 1 995; Smith , Okiyama, Thomas, Claussen, & 
Mcintosh, 1 99 1 ) .  Loss of CA3 dendritic processes is common in focal models of 
TBI (Hicks, Smith , & Mcintosh, 1 995; Taft, Yank, Dixon, & Hayes, 1 992). Axonal 
damage throughout the hippocampus and thalamus is often found, even in the 
absence of DAI (Mcintosh et a I . ,  1 996). Also, receptor binding properties are 
disrupted and the seizure threshold within the hippocampus is lowered (Dixon et 
aI . ,  1 991 ; Feeney et aI . ,  1 98 1 ) .  
Focal models of T B I  have distinctive patterns of histopathological 
changes, including: focal contusion,  hemorrhagic contusion, necrosis, cavitation 
at injury site, short unconsciousness, BBB disruption (primarily in the contused 
region), cerebral edema, decreased cerebral blood flow (CBF), and increased 
metabolism, mircoglial and macrophage prol iferation and recruitment, and the 
potential for delayed secondary insults (Mcintosh et a I . ,  1 996). H istopathological 
studies have shown that the presence of subarachnoid blood may be the only 
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observable pathology at low injury levels. Moderate and severe injuries are likely 
to produce acute and chronic changes such as bi lateral intraparenchymal 
hemorrhage in the hippocampi. At post-acute survival times (post-injury days 4-
7) , necrosis and cavitation become evident at the site of injury (Dixon et a I . ,  
1 987) . Lateral injuries produce radial contusion, structural damage, and cortical 
and hippocampal cell losses which correlate with specific behavioral deficits 
(Delahunty, J iang, Gong, Black, & Lyeth, 1 995). 
Diffuse models of TBI are less l ikely to result in overt cell loss. Using the 
FPI  model,  Delahunty et al. ( 1 995) showed that central injuries produced 
muscarinic and metabotropic dysfunction without any overt cell loss. Small or no 
contusions were observed. 
TBI-Induced Changes 
Temporal Changes: The Biphasic Model 
Experimental TBI initiates a cascade of events that alters normal cell 
signaling and produces neuronal over-excitation (Hayes, Jenkins, & Lyeth, 
1 992). Impact interferes with normal ionic homeostasis. TBI produces an ionic 
flux (e.g. , calcium influx) across the membrane, leading to neuronal excitation 
and depolarization. Excessive neuronal excitation produces large measurable 
increases in extracellular potassium, which result in further depolarization and 
NT release (Faden, Demediuk, Panter, & Vink 1 989; Gorman, O'Beirne, Regan,  
& Williams 1 989; Katayama, Becker, Tamura,  & Hovda, 1 990). Excessive 
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depolarization and NT release may produce changes to the intracellular signaling 
mechanisms, resulting in irreversible or long-lasting alterations in cell functioning 
(Hamm, Temple, Buck, Floyd, & DeFord, 1 999). Following the acute excessive 
excitation of neurons, a chronic phase of functional neuronal depression begins 
(Hubschmann, 1 985). 
The biphasic hypothesis (see Figure 2) posits that there is an acute phase 
« 24h in rats) of excessive neuronal depolarization. Increased levels of 
excitatory NTs and enhanced cerebral metabolism have been demonstrated . 
During the acute phase, methods of intervention that may be useful include 
excitatory receptor antagonists, reductions in glutamate and ACh levels, and 
decreased elevations in metabolism during the first six hours following injury. 
Inhibitory agonists may also help reduce neuronal excitation (Hamm et a I . ,  
1 999). Massive ionic fluxes and EM release following TBI  require high 
metabolic energy, measurable by increased glucose utilization (Alessandri & 
Bullock, 1 998). This hypermetabolism may last for minutes or hours in rat animal 
models and is followed by a hypometabolism lasting days or weeks (Yoshino, 
Hovda, Kawamata, Katayama, & Becker, 1 991 ) .  
The chronic phase (>  24h i n  rats) of depressed neuronal activity has a 
duration that is dependent on the severity level of injury. Decreases have been 
demonstrated in cerebral metabolism, choline uptake, scopolamine-evoked 
release, and choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) 
immunoreactivity ( I R). Excitatory receptor antagonists have been shown to be 
detrimental during the chronic phase, although drugs that attenuate the 
depressed activation of the cholinergic and metabolic systems may be of some 
usefulness (Hamm et aI . , 1 999). 
Ionic Flux and the Role of Calcium 
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As demonstrated in Figure 3, impact is followed by mechanically- and 
chemically-induced ionic flux across the cellular membrane. Ionic alterations lead 
to widespread neuronal depolarization, and indiscriminate NT release (Selzer, 
1 995). Calcium levels increase after injury, especially in damaged regions, and 
may persist for 48 hours following FPI in rats (Fineman et ai, 1 993). 
Mechanically-induced alterations in calcium channel permeabil ity 
contribute to increases in intracellular calcium concentration ([Ca2+]) ,  which lead 
to depolarization and further calcium influx through both NMDA-gated and 
voltage-gated ion channels. NMDA receptor-mediated calcium influx is well 
documented and clearly a critical contributor to excessive intracellular free 
calcium levels (Thomas et a I . ,  1 990; Fineman et aI . , 1 993; Hayes, Jenkins, & 
Lyeth, 1 992). Elevated [Ca2+]; propagates neuronal depolarization and NT 
release, as well as modulating intracellular enzymatic action. I ncreased calcium 
activates proteases such as calpain, which may ultimately lead to cytoskeletal 
degradation and neuronal death . Additionally, calcium activates phosphatases 
such as calcineurin, and kinases such as calcium/ calmodulin kinase type I I  
Figure 2 .  Acute and chronic neuronal activity accord ing to the Biphasic 
Hypothesis 
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(CaM kinase I I ) (Morioka et a I . ,  1 999). The role of intracellular enzymes have not 
been conclusively demonstrated following TBI ,  although preliminary evidence 
indicates that both basal and maximal calcineurin activity is increased in the 
cortex and hippocampus 24 hours following central FPI (Kurz, Gibson, Hamm & 
Churn, 200 1 ) . 
Lethal and Sublethal Cellular Changes 
Indiscriminate NT release includes the inhibitory opioids and GABA, which 
may help to modulate the excitotoxicity induced by release of excitatory NTs and 
amino acids. Pathologically high levels of excitatory NTs (e.g . ,  ACh) and EAA 
(e.g . ,  glutamate and aspartate) are released , leading to excitotoxicity within the 
cells (Mcintosh et a I . ,  1 996). 
Glutamate can produce powerful neurotoxic effects following central 
nervous system (CNS) injuries such as ischemia, hypoxia, and brain trauma 
(Regan & Choi, 1 994) .  Direct exposure can kill neurons (Rothman, 1 985) and 
intermittent excessive exposure can produce delayed cell death (Choi, 1 985; 
Choi, Maulucci-Gedde, & Kriegstein, 1 987). Excitotoxicity has been documented 
acutely for many different types of brain injury. The resulting cascade may 
produce deficits due to either sublethal cell signaling disruptions or overt cell 
death. 
Sublethal excitotoxic injury has been documented in mild to moderate TBI ,  
due partly to processes which depend on muscarinic and NMDA receptors. 
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Dysfunctional cell changes due to excitotoxicity, neurological deficits, 
hippocampal disturbances in cholinergic circuits (which mediate spatial memory) 
and increased vulnerability to secondary insults may occur in the absence of 
overt cellular death or axonal injury (Hayes, Jenkins, & Lyeth, 1 992b). Areas of 
selective vulnerability to CNS insult have been demonstrated in ischemia, 
hypoxia, hypoglycemia, epilepsy, and TBI (Brierly, 1 976). Areas selectively 
vulnerable to sublethal cel lular injury following non-contusional TBI include CA 1 ,  
CA3 and DG regions of the hippocampus and specific layers of the neocortex 
(Hayes, Jenkins, & Lyeth, 1 992b) . 
Glutamatergic Changes 
Glutamate activates three receptor subtypes: NMDA and AMPAIKA (non­
NMDA) ionotropic receptors as well as metabotropic glutamate receptors 
(mGluR). lonotropic receptor activation leads to the opening of ion channels and 
subsequent calcium and sodium influx into the cel l .  Additional calcium is 
released from intracellular stores via second messenger pathways. Ultimately, 
the cascade results in alterations in gene expression and increased energy 
demand from high-affinity glutamate carriers in neurons and astrocytes 
(Alessandri & Bullock, 1 988). 
Extracellular increases in glutamate following FPI in rats peak within 
minutes and may last up to one hour (Faden et a I . ,  1 989; Katayama et aI . , 1 990; 
Nilsson et aI. , 1 990). These increases may be 7-8 fold in the cortex and 3-4 fold 
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in the hippocampus of humans following TBI (Bullock, Maxwell, Graham, 
Teasdale, & Adams, 1 99 1 ) ,  and high levels may persist for up to several days 
(Bullock et aI . , 1 995; Fineman et aI . ,  1 993; Persson et a I . ,  1 996; Robertson et aI . ,  
1 995; Zauner & Bullock, 1 995). Experimental FPI i n  rats produces increases in 
glutamate in the extracellular space that exceed 1 00% of normal within the first 
few minutes following injury. Katayama et al .  ( 1 990) found a 90% increase in 
glutamate in the hippocampus within two minutes following moderate FPI in rats. 
Glutamate levels in the aforementioned study returned to baseline within four 
minutes. Once released , extracellular glutamate binds to a ligand-gated receptor 
( i .e. ,  NMDA or AM PAlKA) , activating the ion channel and producing a large flux 
of cations across the cellular membrane (e.g . ,  calcium and sodium influx, and 
potassium efflux) (Kawamata et a I . ,  1 992; Mcintosh,  Juhler, & Wieloch, 1 998). 
Elevated intracellular cation concentration alters the membrane potential, 
contributing to depolarization and further NT release. 
Blood Brain Barrier Alterations 
Alterations in the BBB introduce exogenous sources of NTs to the brain 
(Hayes, Jenkins, & Lyeth , 1 992a). Moderate TBI without contusion in the rat 
compromises the BBB in the cortex and hippocampus (Povlishock & Lyeth, 
1 989; J iang et aI . , 1 991 ) .  Injury allows greater permeability to exogenous (blood­
borne) NTs and neuromodulators (Koide, Wieloch, & Siesjo, 1 986), and this BBB 
disruption may persist up to1 5  hours (Ell is, Chao, & Heizer, 1 989) . Blood plasma 
ACh levels are 7 -fold greater than CSF levels (Robinson et a I . ,  1 990) and may 
contribute up to 39% to elevated ACh levels found in the CSF following TBI 
(Robinson et aI . ,  1 990). BBB changes allow blood plasma constituents (e.g . ,  
ACh) to access and influence the brain after injury, exacerbating excitotoxic 
effects and receptor dysfunction. 
Excitatory Receptor Changes 
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Several receptor mechanisms exist which may mediate and propagate 
acute post-injury excitotoxicity. Muscarinic cholinergic and ionotropic NMDA 
glutamate receptors show decreased binding following injury (Hayes, Jenkins, & 
Lyeth, 1 992b). Muscarinic cholinergic binding decreases 30-40% in the CA1 and 
DG of the hippocampus by three hours post-injury (Oleniak et aI . , 1 988). Most 
changes in g lutamatergic binding affin ity occur in the NMDA-type receptors. 
NMDA receptor binding has been shown to decrease 1 2-1 5% within three hours 
of moderate TBI in the CA 1 of the hippocampus (Hayes, Jenkins, & Lyeth, 
1 992b). NMDA and non�NMDA (AM PAlKA) receptors are directly correlated to 
selective patterns of vulnerability and damage in specific brain areas following 
TBI . Three hours post-injury, acute decreases in receptor binding for NMDA-type 
receptors have been found in the neocortex (inner and outer layers) and the 
hippocampus (CA 1 stratum radiatum and DG molecular layer). Glutamate 
binding decreases are specific to NMDA receptors and are not seen in AM PAlKA 
glutamate receptors (Mcintosh et aI . , 1 996; Miller et a I . ,  1 990). 
Muscarinic and NMDA receptor interactions (via G proteins and the I P3 
pathway) have been implicated in aberrant intracellular effector cascades 
following TBI (e.g. , changes in intracellular effectors, coupling efficiency, and 
early effector genes). The above interactions may play an important role in 
sublethal TBI pathology. Sublethal injury has been associated with decreased 
CA 1 muscarinic and NMDA receptor bind ing, increased CA 1 sensitivity to 
forebrain ischemia (first 24 hours) ,  EEG spike frequency from the affected CA 1 
region, spatial memory deficits in the intact hippocampus and Schaeffer­
collateral CA 1 long-term potentiation (L TP) suppression (Hayes, Jenkins, & 
Lyeth, 1 992b). 
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Excitatory receptor antagonists have been shown to have some 
usefulness acutely in attenuating the detrimental effects of TBI pathophysiology. 
NMDA antagonists such as MK-801 ,  phencyclidine (PCP) and dextrorphan have 
been shown to be beneficial in rat TBI models. Another potentially beneficial 
treatment is the muscarinic ACh receptor antagonist scopolomine. These drugs 
are unl ikely to be highly effective in a clinical setting, however, due to their 
potential toxicity, detrimental side effects, and the very short therapeutic window 
(maximum 1 5-30 minutes in rats) (Hayes, Jenkins, & Lyeth , 1 992b; Mcintosh et 
aI. , 1 996; Faden et a I . ,  1 989). In  a pre-cl inical setting, however, they may provide 
valuable insight into mechanisms that drive neuronal excitotoxicity. 
The Role of Intracellular Calcium 
4S 
Glutamate Receptors 
Glutamate is the most abundant excitatory neurotransmitter in the brain,  
with receptors on nearly all neurons (Kandel, Schwartz, & Jessell, 1 991 ) .  
AMPAIKA glutamate receptors gate a low conductance channel permeable to 
sodium and potassium (but not calcium). The NMDA glutamate receptor subtype 
gates a high conductance cation channel permeable to sodium, potassium, and 
calcium. Glutamate binds to the NMDA receptor, opening the channel. The 
NMDA ion channel, however, contains a voltage dependent Mg blockade that 
must be displaced before efficient ion conductance can occur (Kandel, Schwartz, 
& Jessell, 1 991 ; Mcintosh ,  Juhler, & Wieloch , 1 998). AM PAlKA receptors are 
primarily responsible for depolarization of the cel l .  NMDA receptors have delayed 
activation, depending on cellular depolarization to remove the Mg block (8ading 
et a I . ,  1 995; Hestrin ,  N icoll ,  Perkel, & Sah, 1 990). Non-competitive NMDA 
antagonists such as phencyclid ine (PCP) and dizoci lipine (MK-80 1 )  bind to sites 
within the ion channel, effectively blocking calcium and sodium influx (Foster & 
Wong, 1 987; Kandel, Schwartz, & Jessell, 1 991 ; Olney, Price, Salles, Labruyere, 
& Frierdich, 1 987; Ransom & Stec, 1 988). The NMDA receptor is the only 
ionotropic glutamate receptor that allows calcium influx. Calcium influx through 
the NMDA channel is the primary source of glutamate-related excitotoxicity 
(8ading et aI . , 1 995; Hayes, Jenkins, & Lyeth, 1 992b; Kandel, Schwartz, & 
Jessell, 1 991 ; Regan, 1 996). High [Ca2+]; may produce free radicals (e.g . ,  
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hydroxyl radicals) (Laplanche, Kamenka, & Barbanel, 2000); activate proteases, 
phosphatases, and lipases (Kandel, Schwartz, & Jessell, 1 991 ; Morioka et aI . , 
1 999); alter gene expression at the transcriptional and translational levels 
(Bading et aI . ,  1 995; Barish,  1 998; Marin et aI . , 1 997; Rosen, Ginty, & 
Greenberg, 1 995; Scheetz, Nairn, & Constantine-Paton, 1 997); and interfere with 
transportation and insertion of proteins into the cellular membrane (Barish et a I . ,  
1 998). 
Genetic Factors 
The Process of Transcription and Translation 
At the molecular level, proteins are a product of a sequence of calcium­
regulated events. Transcription refers to the formation of RNA from DNA. During 
this process, nucleotides transcribe a portion of a DNA strand into mRNA. There 
are four primary steps involved in transcription: 1 )  RNA polymerase binds to 
DNA, 2) transcription is initiated on the DNA strand; 3) the RNA chain is 
elongated , and 4) transcription is terminated and the RNA is released (Kolb & 
Wishaw, 2001 ; Parker, 1 994; Pinel, 2000). Many transcriptional regulators, which 
mediate each phase of this process, are regulated by cytosolic [Ca2+] (Barish, 
1 998) . 
Translation refers to the formation of a protein (protein synthesis) from 
transcribed mRNA. Ribosomes in the endoplasmic reticulum (ER) translate 
mRNA codones (a group of three consecutive nucleotide bases) into amino 
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acids, which are added to a peptide chain by tRNA to form a polypeptide chain. 
The steps in translation include: initiation, elongation of the polypeptide chain ,  
and termination .  Intracellular stores of  calcium in organelles such as the ER play 
important roles in the regulation of each step of protein synthesis (Barish, 1 998; 
Palfrey and Nairn, 1 995). 
Calcium. gene expression, and the NMDA Receptor 
The regional pattern of [Ca2+]; and the route of Ca2+ entry are critical 
factors in gene regulation. NMDA-mediated elevations in [Ca2+1; in cultured 
hippocampal neurons have been shown to produce an up-regulation of 
immediate early gene ( lEG) expression at the level of transcription. Calcium 
influx through voltage-gated receptors was not sufficient to produce these 
transcriptional changes (Bading et a I . ,  1 995). At the translational level, NMDA 
receptor activation induces the phosphorylation of eukaryotic translation 
elongation factor 2 (eEF2), which results in a depression of protein synthesis. 
Phosphorylation of eEF2 is dependent on NMDA receptor activation and may 
represent a sublethal protective mechanism against glutamatergic excitotoxicity 
(Marin et aI . ,  1 997; Scheetz, Nairn, & Constantine-Paton, 1 997). 
Protein Activation. Transport, and Membrane Insertion 
Following translation, the completed polypeptide chain folds into a specific 
conformation. The finished protein may be held in the ER until it is transported 
and inserted into the plasma membrane. Calcium regulates the enzymes (e.g . ,  
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kinases and phosphatases) responsible for activation and deactivativation of 
proteins via phosphorylation factors ( Brandon et a I . ,  2000; Churn & Delorenzo, 
1 998; Krishek et a I . ,  1 994; McDonald et aI . , 1 998; Morioka et aI . , 1 999; Robello, 
Amico, & Cupello, 1 997; Stelzer & Shi, 1 994) .  
Although little is known about the role of  calcium in membrane protein 
transport and insertion, [Ca2+]; may regulate the phosphorylation states of the 
motor proteins (kinesin and dynein) responsible for transporting proteins to the 
surface membrane (Barish, 1 998; Hirokawa, 1 998). Calcium may also play a role 
in insertion of proteins into the membrane (Barish, 1 998). 
Receptor interactions 
Transient increases in [Ca2+]i can be blocked by voltage-gated calcium 
channel blockers. Excessive [Ca2+]; elevations, however, are primarily mediated 
by NMDA receptors (Bading et a I . ,  1 995; Fekuda et a I . ,  1 998). Preliminary 
evidence from Sun et al. (2001 )  indicates that basal [Ca2+]; is elevated in acutely 
isolated hippocampal neurons 24 hours and 6 days following TBI .  Additionally, 
injured neurons take significantly longer to return to basal [Ca2+]; following 
glutamate exposure (50IJM, 2 min). 
Elevated [Ca2+]; plays a role in desensitizing the y-aminobutyric acid type 
A (GABA-A) receptor. Mozrzymas and Cherubini (1 998) used the whole cell 
patch-clamp technique to study the effects of high (2 .2  x 1 0-6 M) or low (1 .2  x 1 0.8 
M) levels of [Ca2+]; on GABA-A receptors in acutely dissociated rat hippocampal 
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slices. High levels of [Ca2+]; significantly reduced GABA-evoked chloride (CI-) 
currents and increased desensitization kinetics of GABA-A receptors. Similar 
results were found in mouse cortical neurons. I ncreases in NMDA receptor­
mediated [Ca2+]; reduced CI- current amplitude. Transient increases in low levels 
of [Ca2+]; ,  however, enhanced the maximal response to GABA. This 
enhancement was blocked by a CaM kinase II inhibitor (Aguayo, Espinoza, 
Kunos, & Satin ,  1 998). Inhibition of GABA-A receptor CI- current gradients 
exacerbates [Ca2+]; elevations, although this effect can be blocked by NMDA 
receptor antagonists. Therefore, GABA, the primary inhibitory NT in the brain, 
may exacerbate neuronal excitotoxicity if there is a reduction in the CI­
equilibrium potential (Fukuda et a I . ,  1 998). 
Treatment of the inhibitory system following TBI has been studied using 
chronic endpoints, although the effects are less well characterized than 
eXCitatory NT and receptor antagonists. Following injury, chronic injections of 
pentylenetetrazol, a GABA-A receptor antagonist, induced seizure activity which 
enhanced injured and harmed sham cognitive performance in the Morris water 
maze (MWM) (Hamm, Pike, Temple, O'Dell , & Lyeth, 1 995). Treatment with MDL 
26,4791 Suritozole, a GABA-A receptor inverse agonist, was found to be effective 
in attenuating MWM deficits (O'Dell & Hamm, 1 995). A single acute injection of 
Diazepam within 1 5  minutes of injury has also been shown to effectively improve 
MWM performance (O'Dell ,  Gibson, Wilson,  DeFord, & Hamm , 2000). 
Collectively, these findings would ind icate that acute modulation of the 
GABAergic system has beneficial effects on attenuating TBI-induced chronic 
cognitive deficits. 
Understanding Inhibitory Neuroprotection 
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The overexcitation induced by TBI is also characteristic of other types of 
CNS insults. Excessive excitation alone, however, is unlikely to represent the 
entire story behind the cascade of events that occurs following injury. It is likely 
that the normal neuronal balance between excitation and inhibition has been 
disrupted, resulting in neurotoxicity. Alternative to decreasing excitation, balance 
may also be restored by increasing inhibition. Impaired inhibition of neocortical 
pyramidal neurons has been found following hypoxia combined with lowered 
brain temperature (Fujisaki, Wakatsuki, Kodoh, & Shibuki, 1 999). Additionally, 
lateral FPI produces regionally specific alterations in inhibition. Reeves et al. 
(1 997) demonstrated a reduction in the strength of paired-pulse depression in 
the hippocampal CA3 to CA 1 commissural input, which returned to baseline by 
1 5  days post-injury. The EC input to the OG and CA 1 ,  however, showed a 
strengthening of inhibition that remained essentially constant from two to fifteen 
days following injury and was qualitatively associated with an increase in GABA 
IR.  The SLM layer in the CA 1 of the hippocampus receives input from the EC, 
and persistent elevations of GABA have been demonstrated in this layer at one 
and fifteen days following TBI (O'Oell, 1 995). Increased inhibitory input from the 
EC during the chronic phase of TBI pathophysiology may be a compensatory 
mechanism responding to the acute excitatory phase. 
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Inhibitory agonists have been studied extensively in ischemia and are 
neuroprotective when administered within the first four hours following injury 
(Cross, Jones, Baldwin & Green, 1 991 ; Inglefield, Wilson & Schwartz-Bloom, 
1 997; Li, Siegel, & Schwartz, 1 993; Schwartz, Huff, Yu, Carter, & Bishop, 1 994; 
Schwartz et aI . , 1 994; Shauib & Kanthan, 1 997). Diazepam and other GABA-A 
receptor agonists, when administered before or shortly after ischemic injury, 
have been shown to be protective against morphological cell damage 
(Nishikawa, Takahashi ,  & Ogawa, 1 994) and CA1 pyramidal cell loss (Cross et 
aI . ,  1 991 ; Fujisaki, Wakatsuki, Kudoh, & Shibuki, 1 999; Inglefield , Wilson, & 
Schwartz-Bloom, 1 997; Johansen & Diemer, 1 991 ; Schwartz-Bloom et a I . ,  1 998; 
Wahlgren, 1 997), as well as attenuating GABA-A receptor binding detriments 
(Arika, Kanai, Murakami, Kato , & Kogure, 1 993; Inglefield , Wilson, & Schwartz­
Bloom, 1 997) and injury-induced decreases in CI- channel currents (Sigel, Baur, 
Trube, Mohler, & Malherbe, 1 990). Diazepam has also demonstrated its 
effectiveness in cognitive protection in TBI (O'Dell et a I . ,  2000). 
A majority of the research regarding GABA-A receptor agonist-mediated 
neuroprotection has been done in ischemia. TBI and ischemia share similar 
pathologies. Both injuries culminate in excitotoxic consequences affecting 
selectively vulnerable brain regions. I mportant differences exist between the two 
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types of CNS injuries. Global ischemia lowers MABP and brain temperature 
( Inglefield, Wilson , & Schwartz-Bloom, 1 997) but moderate diffuse TBI does not 
significantly alter either of these measures (O'Dell et aI . , 2000). The most studied 
brain region in ischemia research is the hippocampus (Shauib & Kanthan, 1 997), 
where an important morphological difference between injury types is evident. 
The CA 1 region of the hippocampus shows delayed degeneration at three to four 
days post-ischemia (Li , Siegel, & Schwartz, 1 993), whereas diffuse TBI does not 
tend to exhibit overt cell loss and focal TBI selectively destroys CA3 and DG hilar 
neurons (Hayes, Jenkins, & Lyeth, 1 992). 
The excitatory input in the hippocampus is balanced by inhibitory 
processes, often on the same cell .  Pyramidal neurons receive synaptic input 
from both glutamate and GABA receptors (Li, Siegel, & Schwartz, 1 993). 
Glutamate is a precursor to GABA, and is formed when glutamic acid 
decarboxylase (GAD) , which is only found in neurons, removes a carboxyl group 
from glutamate (Luddens, Korpi, & Seeburg, 1 995). GABA is the most prevalent 
inhibitory neurotransmitter in the brain, exerting its effects primarily through the 
GABA-A receptor complex. 
The GABA-A receptor acts to increase membrane hyperpolarization via 
modulation of a CI- channel. The GABA-B receptor differs from the GABA-A 
receptor in both mechanism of action and neuroprotective potential .  The GABA­
B receptor acts primarily through a G-protein-coupled second messenger system 
53 
to reduce the presynaptic release of various neurotransmitters (Karlsson & Olpe, 
1 989). Modulation of the GABA-B receptor does not show neuroprotection in 
ischemia (Araki, Kato, & Kogure, 1 99 1 ;  Ito, Watanabe, Isshiki, & Uchino, 1 999). 
The third type of GABA receptor, GABA-C, is an ionotropic receptor found only in 
retinal bipolar and horizontal cells (Feigenspan, Wassle and Bormann, 1 993; 
Quian and Dowling, 1 993; Lukasiewicz, 1 996) and is insensitive to 
benzodiazepines and other GABA-A agonists (Sivilotti and Nistri, 1 991 ; Bormann 
and Feigenspan ,  1 995; Johnston, 1 996). 
The GABA-A receptor is potentiated by ligands which bind to sites specific 
for benzodiazepines (BZs) , barbiturates, alcohol, steroids, zinc ions (Zn+), or 
various anesthetics (Marrow, 1 990; Roberts, 1 974) .  As many as 20-50% of all 
synapses in the CNS use GABA as a neurotransmitter (Bloom & Iversen, 1 971 ) .  
Other estimates contend that GABA-A receptors may be  present on  all neurons 
in the brain (Wahlgren, 1 997). 
Specific areas of the hippocampus, such as the SO and SR layers of the 
hippocampus proper, have been estimated to use GABA in 80-95% of the 
synapses. Although the pyramidal cell layer represents a much lower percentage 
of GABA-positive cells (5-8%), approximately 1 1  % of the general hippocampal 
neuronal population is GABAergic (Woodson ,  Nitecka, & Ben-Ari, 1 989). The 
prominent expression of GABA-A receptors in h ippocampal interneurons 
indicates that inhibition is an important mechanism for maintaining excitatory/ 
inhibitory balance in neurons (Gao & Fritschy, 1 994). 
The Relationship Between Excitatory and Inhibitory Processes 
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The relationship between excitatory and inhibitory processes is complex. 
ACh is closely associated with GABA, and GABAergic inhibition decreases ACh 
levels. The mechanism involved in the ACh-GABA relationship is poorly 
understood, but it is bel ieved to be mediated via GABA receptors on cholinergic 
neurons (DeBoer & Westerink, 1 994) .  GABA and muscimol (a GABA-A agonist) 
enhance cholinergic release and this effect is blocked by biciculline (a GABA-A 
antagonist), indicating that the GABA-A receptor complex plays a modulatory 
role in ACh release (Supavilai & Karobath, 1 985). 
Group I mGluRs have been implicated in the excitation of neurons in the 
CA 1 of the hippocampus. Classified by their pharmacological profiles, Group I 
mGluRs include mGluR1 and mGluR5. The Group I mGluRs not only excite 
neurons via depolarization by glutamate release, but they also play a role in 
regulating GABA release. GABAerg ic interneurons in the hippocampus are 
activated by mGluRs either pre- or post-synaptically. Group I mGluRs increase 
neuronal excitation by co-localizing on neurons which also contain GABA-A 
receptors. Group I I  mGluRs are located on inhibitory terminals and act to reduce 
pre-synaptic GABA release. In the CA 1 of the hippocampus, Group I mGluRs 
modulate pyramidal cell input from GABAergic interneurons. Activation of Group 
I mGluRs on inhibitory interneurons in the hippocampus contributes to the 
overexcitation which is associated with epilepsy and may play other important 
roles in disrupting the excitatory- inhibitory balance (Bordi & Ugolini , 1 999). 
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As would be expected by the importance of mGluRs in GABAergic 
balance, NMDA-type glutamate receptors and GABA-A receptors are co­
local ized in hippocampal neurons (Craig, Blackstone, Huganir, & Banker, 1 994). 
Modulation of NMDA glutamate receptors by MK-80 1 antagonism decreases 
GABA-A receptor-mediated CI- uptake by 44% in the hippocampus (Matthews, 
Dralic, Devaud,  Fritschy, & Marrow, 2000). Stimulation of GABA-A receptors has 
been shown to be protective against neuronal injury induced via NMDA receptor 
activity. GABA-A agonists block NMDA-induced damage and this protection can 
be reversed by GABA-A antagonists such as biciculline (Ohkuma, Chen, 
Katsura,  Chen, & Kuriyama, 1 994). 
Interactions between NMDA receptors and GABAergic inhibition are also 
important to L TP. Central FP I  produces impaired L TP capacity in the CA 1 of the 
hippocampus at two and fifteen days post-injury. Qualitatively associated with 
these changes in LTP are decreased NMDA receptor (NMDAR1 subunit) IR and 
increased GABAergic IR in the CA1 . Decreased NMDA receptor activity and 
increased GABAergic activity correspond well with decreased L TP chronically 
following TBI ,  providing some insight into the physiological and neurochemical 
mechanisms associated with TBI-induced deficits in spatial learning (Reeves, 
Zhu, Povlishock, & Phill ips, 1 997). 
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Whole cell voltage clamp studies have demonstrated that NMDA and 
glutamate application diminish GABA-A receptor activation in acutely isolated 
hippocampal cells (Chen & Wong, 1 995; Stelzer & Shi, 1 994) and in cerebellar 
granule cells (Robello, Amico, & Cupello, 1 997) .  NMDA reduced GABA-A 
outward current, although this effect was reversed when extracellular calcium 
was replaced with barium. Intracellular perfusion of calcineurin, a calcium­
dependent phosphatase, also suppressed GABA-A responses (Chen & Wong, 
1 995; Stelzer and Shi ,  1 994) ,  and this suppression was reversed by the 
calcineurin inhibitor deltamethrin (Robello, Amico, & Cupello, 1 997). Calcium 
currents activated by voltage dependent channels d id not alter GABA-A receptor 
responses. These data indicate that NMDA-mediated calcium influx alters 
GABA-A receptor activity. Activation of the phosphatase calcineurin has been 
implicated in the dephosphorylation of the GABA-A receptor complex (Chen & 
Wong, 1 995; Robello, Amico, & Cupello, 1 997; Stelzer & Shi, 1 994). 
The GABA-A Receptor 
The GABA-A receptor is part of a superfamily of neurotransmitter-gated 
ion channels which includes nicotinic ACh receptors, glycine receptors and 
glutamate receptors (Sigel & Buhr, 1 997; Schwartz, 1 988). GABA-A receptors 
mediate the majority of CNS inhibitory neurotransmission (Mohler et a I . ,  1 996) .  
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The fast-acting GABA-A ion channel reacts within milliseconds to receptor 
activation by ligand-binding, initiating the opening or gating of a CI- channel 
(Stephenson, 1 995). GABA-A receptors help regulate anxiety, vigilance, 
memory, convulsive activity and muscle tension (Mohler et a I . ,  1 996). Although 
the binding sites are distinct, through ligand-mitigated action they initiate 
complex interactions with each other (Kandel, Schwartz, & Jessell ,  1 991 ; 
Sieghart, 1 995). The binding of one ligand increases the affinity for other ligands 
(e.g . ,  benzodiazepine binding increases receptor binding affinity for GABA). 
Activation of the GABA binding site produces a conformational change in the 
receptor, increasing the binding capabi lities of other ligands and ultimately 
increasing CI- flux and neuronal hyperpolarization (Li , Siegel, & Schwartz, 1 993; 
Lyden, 1 997; Sieghart, 1 995). GABA-A receptor activation also reduces glucose 
metabolism and mediates cerebral blood vessel di lation, improving blood flow 
(Lyden, 1 997). 
GABA-A Receptor Subunits 
The GABA-A receptor has a pentameric structure (Lyden, 1 997). The 
heterogeneity of the formation of the receptor by its constituent subunits has 
prompted it to be referred to as a "heterooligomeric complex" (Matthews et aI . ,  
2000; Backus et aI . ,  1 993), which is a common subunit composition for ligand­
gated ion channels (Backus et a I . ,  1 993). Six subunits, most with several 
isoforms, have been identified, including: 0H' 131-4' Y1.3' 6, n, and P1.3 (Luddens & 
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Wisden, 1 991 ; Pritchett, Luddens, & Seeburg, 1 989a; Pritchett et aI. , 1 989b; 
Schofield , 1 989; Sieghart, 1 995; Smith & Olsen, 1 995). Each subunit is encoded 
by a different gene (Sieghart, 1 995), and contains both a hydrophil ic NH2 (N) 
terminal and a cystine (C) terminal domain. Subunits consist of four 
transmembrane helices (M1 -M4) and a large intracellular loop located between 
M3 and M4 (Burt & Kamatchi ,  1 991 ; MacDonald , Saxena, & Angelotti , 1 996; 
Olsen & Tobin, 1 990). The N-terminal lies between the M1 and M3 domains and 
the M2 domain lines the inside of the CI- channel (Kandel, Schwartz, & Jessell, 
1 991 ; Stephenson, 1 995). The M2 domain is positively charged and bel ieved to 
be responsible for anion selectivity of the CI- pore (Kandel, Schwartz, & Jessell, 
1 991 ) .  The large intracellular domain of the GABA-A receptor subunit contains 
multiple potential sites for protein phosphorylation by protein kinases (Moss, 
Doherty, & Huganir, 1 992). 
Each type of subunit (e.g . ,  0 and r3) shares 30-40% of their amino acid 
sequence. Within a subunit type, the different isoforms (e.g . ,  0 1  and 02) have 
70% identical amino acid sequences. Amino acid GABA-A receptor sequences 
are conserved approximately 90% across mammalian species (Stephenson, 
1 995). Each type of subunit is d istinctively different in its encoded sequence and 
its function .  However, due to the similarity between the subunit constituent 
sequences, changes to a single amino acid residue can drastically change 
receptor stoichiometry and binding properties (Buhr & Sigel, 1 997). Although 
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recombinant receptors containing one, two, three, four, or five subunits have 
been identified, the most common form in vivo contains three subunits (Persohn, 
Malherbe, & Richards, 1 992; Wisden & Seeburg, 1 992). Of the five identified 
subunits, a ,  �, and y are considered the "main" subunit types, while <5, n, and p 
are considered "minor" subunit types (Lyden, 1 997; Mohler et aI . , 1 996). The <5, 
n, and p subunits are considered minor because they are rare and not widely 
distributed . The remaining three subunits (a, �, and y) have several isoforms, 
each of which combines to form a wide array of receptor types (see Table 3 for a 
summary). GABA-A receptors with specific subunit combinations confer specific 
functions and distributions within neuronal tissue. The most abundant subunits 
are a 1 ,  a2,  a3,  �2, �3, and y2 (Stephenson, 1 995) . 
GABA-A receptors with a �y subunit combinations are the most widely 
distributed receptor type and this combination is important for proper 
benzodiazepine (BZ) binding (Sieghart, 1 995). The most abundant GABA-A 
receptors in the rat brain consist of 2a, 1 �  and 2y subunits, although 2a, 2�, and 
1y is also a common subtype (Backus et aI . , 1 993) (See Table 3). Specific brain 
regions, such as the hippocampus, contain more or less abundant populations of 
GABA-A receptor subtypes. One of the most expressed receptor subtypes in the 
hippocampus is a2�3y2, although in other areas of the brain a 1 �2y2 GABA-A 
receptors are most abundant (Sieghart, 1 995). In the hippocampus, GABA-A 
receptors on interneurons tend to be the a 1 �2y2 subytpe, whereas receptors on 
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pyramidal and granule cells tend to be the a2133y2 subtype (Barnard et a I . ,  1 998; 
Mohler et a I . ,  1 996). Overal l ,  75% of all GABA-A receptors are made up of three 
receptor subtypes: a 1 132y2, a2133y2, and a3133y2 (Mohler et a I . ,  1 996). 
The relative abundance of subtypes and heterogenous clustering of 
certain types of receptors in different brain areas has increased the 
understanding of the role that each subunit plays in the overall function of the 
GABA-A receptor. The binding site for BZs lies on the y subunit at the a junction 
(Sieghart, 1 995) (See Figure 4). The BZ binding site location determines its 
function ,  indicating that although a contributes to binding specificity, the 
presence of either y2 or y3 is required for proper BZ action (Luddens, Korpi, & 
Seeburg, 1 995; Persohn, Malherbe, & Richards, 1 992; Somogyi, Fritschy, 
Benke, Roberts, & Sieghart, 1 996; Stephenson, 1 995; Wisden et ai , 1 992). The 
widespread action of BZs may be explained by the relative abundance of y2 
subunits (40-50% of GABA-A receptors) in rat brains (Benke, Mertens, Trzeciak, 
Gillessen, and Mohler, .1 991 ) . Similarly, the GABA binding site's location on the 13 
subunit explains the presence of 13 in nearly every known receptor subtype. 
Since the GABA binding site is near the al3 junction (Refer to Figure 4), it also 
follows that a plays an important role in GABA binding affinity, although this 
remains to be definitively determined (Huh, Delorey, Endo, & Olsen , 1 995; 1 996; 
Stephenson, 1 995). 
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Unassembled GABA-A receptor subunits are retained i n  the endoplasmic 
reticulum (Gorrie et aI . , 1 997). GABA-A receptor surface stability is regulated by 
specific subunit isoforms and protein kinases (Connolly et aI . , 1 999). Protein 
kinases, includ ing protein kinase C, protein kinase A, and CaM kinase I I ,  have 
been shown to be involved in the phosphorylation of � and y subunits at specific 
intracellular serine residues (Ser-409, Ser-4 1 0  and in �3 only, Ser-408) (Brandon 
et aI . , 2000; Churn & Delorenzo, 1 998; Krishek et a I . ,  1 994; McDonald et a I . ,  
1 998; McDonald & Moss, 1 997; Moss, Doherty, & Huganir, 1 992). 
Phosphorylation of GABA-A receptor subunits by CaM kinase II increases CI­
conductance by increasing the availabil ity of receptors. Increased neuronal 
excitability due to seizure activity and glutamate excitotoxicity decreases CaM 
kinase II phosphorylation of GABA-A receptor subunits (Churn & Delorenzo, 
1 998; Churn ,  Limbrick, Sombati, & Delorenzo, 1 995; Wang, Cheng, Kolaj, & 
Randic, 1 995; Yamagata & Obata, 1 998). 
The � subunits play a unique role in subcellular distribution and may be 
involved in the relocation of GABA-A receptors between subcellular locations. 
The �3 subunit shows a unique abil ity to transcytose, providing a mechanism for 
receptor isoform relocation (Connolly, Wooltorton, Smart, & Moss, 1 996). The y2 
subunit interacts with the cellular protein GABA-A-receptor-associated protein 
(GABARAP). GABARAP has similarities with microtubule-associated proteins 
and contains a tubulin binding motif on its N terminus. Interactions between y2, 
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Figure 4. A diagram of an abundant subtype of the GABA-A receptor, identifying 
GABA and BZ bind ing sites. The subunits are arranged around a central chloride 
pore. 
63 
I = GABA b ind ing  s i te 
• = Benzodiazepine b ind ing  s ite 
Table 3 .  The characteristics of  GABA-A receptor subunits and their isoforms. 
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Properties of the GABA-A Receptor Subunits 
. .'�. ". , . "" '_I�-.. _2���fu�_� r��;�:��L��� �i1k�:�A.a.o��� � 
Important to BZ and other ligand binding properties 
Tends to co-localizes with P2 or p3 and y2 or y3 
a1 Most abundant a subunit in rat brain 
Found in 90% of cortical and 40% of hippocampal GABA-A receptors 
Co-localizes with P2 or p3 and y2 in 70-75% of GABA-A receptors 
with a1 
a2 Second most abundant a subunit in rat brain 
Tends to co-localize with P3 and y2 
a3 Tends to co-localize with P2 or p3 and y2 
a. Rarest form of a 
as Low abundance (but is found in CA 1 and CA3 of the hippocampus) 
a6 Only found in cerebellar granule cells and cochlear nucleus granule 
cells 
Found in all in vivo GABA-A receptors investigated 
Contains binding site for GABA (on p, at a p junction) 
Role in subcellular receptor distribution 
P1 Low distribution, not much in the hippocampus 
P2 Most abundant p subunit in rat brain 
Tends to co-localize with a 1  and Y2 
P3 Role in receptor expression (can transcytose) 
Tends to co-localize with a2 and Y2 
13. Only found in chick brains 
Contains binding site for BZ (on y, at ay junction) - Y2 and y 3 only 
Y1 BZ-insensitive receptors 
Y2 Most abundant y subunit in rat brain 
BZ-sensitive receptors 
Y3 Rare 
BZ-sensitive receptors 
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GABARAP, and tubulin, therefore, may be important in the anchoring of GABA-A 
receptors to the cytoskeleton (Wang, Bedford , Brandon, Moss, & Olsen, 1 999). 
Modulation of the GABA-A Receptor by Ligand Binding 
The numerous binding sites on the GABA-A receptor translate into 
complex pharmacological potential. Agonists acting at the GABA-A receptor, 
however, have consistently demonstrated their acute effectiveness in several 
types of CNS insults (Arika et aI . , 1 993; Cross et a I . ,  1 991 ; Gibson, 2000; 
Inglefield , Wilson, & Schwartz-Bloom; Ito et aI . , 1 999; Johansen and Diemer, 
1 991 ; Matthews et a I . ,  2000; O'Dell and Hamm, 1 995; O'Dell et aI . , 2000; 
Schwartz et a I . ,  1 994; Schwartz-Bloom et aI . ,  1 998; Shauib and Kanthan, 1 997; 
Wahlgren, 1 997) while antagonists are likely to exacerbate injury-related deficits 
acutely (Hernandez, Heninger, Wilson, & Gallager, 1 989; Ito et a I . ,  1 999; O'Dell 
et a I . ,  20000; Ohkuma et a I . ,  1 994). 
Although GABA-A receptor binding sites interact, they have unique 
pharmacological qualities, and some provide greater neuroprotection than others 
against CNS injury. Barbiturates such as pentobarbital are ineffective in 
preventing neuronal degradation following ischemia (Araki, Kato, & Kogure, 
1 99 1 ; Ito et a I . ,  1 999). Partial GABA-A agonists such as Ro 1 6-6028 and 
imidazenil show limited protection in ischemia (Hernandez et a I . ,  1 989; Schwartz­
Bloom et aI . ,  1 998). Drugs that act to increase GABA (muscimol) or prevent 
GABA transferase (GABA-T) from removing GABA from the synapse (gamma-
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vinyl GABA, No-328) also provide effective neuroprotection after injury (Ito et aI . , 
1 999; Johansen & Diemer, 1 99 1 ;  Katoh, Shima, Nawashiro, Wada, & Chigasaki, 
1 998; Shauib & Kanthan, 1 997; Wahlgren, 1 997). Other GABA-A receptor 
modulators such as chlormethiazole and MDL 26,479 (Suritozole) are at least 
partially neuroprotective (Cross et aI . , 1 99 1 ;  Fujisaki et a I . ,  1 999; Johansen & 
Diemer, 1 99 1 ;  Shauib & Kanthan, 1 997; Wahlgren, 1 997). The most widely used 
and most demonstrably effective drugs in neuroprotection are the 
benzodiazepines (BZs) , diazepam (DZ) in particular. DZ has consistently 
demonstrated its effectiveness in providing neuroprotection following CNS insult 
(Gibson,  2000; Hernandez et a I . ,  1 989; Inglefield et a I . ,  1 997; Johansen & 
Diemer, 1 99 1 ;  O'Dell et a I . ,  2000; Schallert, Hernandez, & Barth, 1 986; Schwartz 
et a I . ,  1 994; Schwartz-Bloom et aI . , 1 998; Sigel et aI . , 1 990). Working memory 
enhancement (Moran, Kane, & Moser, 1 992) and cognitive deficit attenuation 
following TBI (O'Dell et a I . ,  2000) have also been attributed to DZ treatment. 
Benzodiazepines such as DZ bind to the GABA-A receptor, instigating a 
conformational change that al lows GABA to bind more readily and more tightly. 
I ncreased GABA stimulation of the receptor increases the potency and 
frequency of CI- channel opening. Each receptor may have a BZ binding site 
located on each of the constituent V subunits, and an additive effect may occur 
when combined with barbiturates or GABA agonists. The presence of GABA is 
required for proper BZ action (Kandel, Schwartz, & Jessell, 1 991 ; Sieghart, 
1 995). 
Immunoreactivity in the Hippocampus 
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The hippocampus has been well-characterized with regards to GABAergic 
immunoreactivity ( IR) .  Anti-GAD and anti-GABA antibodies have demonstrated 
that dendritic fields and interneurons in the CA 1 ,  CA3 and hilar regions of the 
hippocampus are GABAergic (Gamrani ,  Onteniente, Seguela, Gefferd, & 
Calas, 1 986; N ishikawa, Takahashi ,  & Ogawa, 1 994; Terai ,  Tooyama, & Kimura,  
1 998; Woodson, N itecka, & Ben-Ari, 1 989). GABA and GABA-A receptor 
staining are not always co-localized, however. The neurotransmitter GABA is 
likely to be found in the nucleus, cytoplasm and in the synapses, especially of 
interneurons (Gao & Fritschy, 1 994; Inglefield , Wilson, & Schwartz-Bloom; Li, 
Siegel, & Schwartz, 1 993; Mizuhami et a I . ,  1 997; Somogyi et aI. , 1 996; Terai ,  
Tooyama, & Kimura ,  1 998). In  an in situ hybridization characterization of a1 and 
(32 in the hippocampus, Li , Sigel and Schwartz demonstrated in 1 993 that GABA­
A receptor subunits reside predominantly on non-pyramidal cells. y2 subunits, 
which tend to co-localize with a 1  and (32 or (33, are highly expressed in dendritic 
layers and on interneurons (Somoygi et a I . ,  1 996) . A majority of the interneurons 
in the hippocampus are the a 1  (32y2 subtype. In pyramidal cells and DG granule 
cells, (33 tends to co-localize with a2 or a5 and y2 to form GABA-A receptor 
complexes (Barnard et a I . ,  1 998; Mohler et aI . , 1 996). 
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Using an antibody specific for 132 and 133 subunits (132/3) of the GABA-A 
receptor, Gibson (2000) found changes in the CA3 region of the hippocampus 24 
hours following central FPI .  Although the overall number of stained processes 
was not altered , the IR length of CA3 apical dendrites was decreased following 
injury. Additionally, qualitative alterations were found in the appearance of IR 
processes. Specifically, the dendrites had a varicose beaded appearance. 
Similar beading has been found following ischemia ( Inglefield , Wilson , & 
Schwartz-Bloom, 1 997) and in cultured neurons exposed to NMDA or A23 1 87 (a 
calcium ionophore) (Emery & Lucas, 1 995). Administration of diazepam 1 5  
minutes prior to injury normalized qual itative and quantitative alterations in 132/3 
IR (Gibson, 2000). 
TBI and the GABA-A Receptor 
It is essential to proper functioning that the hippocampus maintain an 
appropriate excitatory/ inhibitory balance. TBI may disrupt this balance. GABA-A 
receptors mediate the majority of CNS inhibitory neurotransmission (Mohler et 
a I . ,  1 996) and may be present on all neurons in the brain (Wahlgren, 1 997). The 
prominent expression of GABA-A receptors in h ippocampal interneurons 
ind icates that inhibition is an important mechanism for maintaining neuronal 
balance (Craig et a I . ,  1 994). 
Modulation of NMDA glutamate receptors by MK-801 antagonism 
decreases CI- uptake mediated by GABA-A receptors in the hippocampus 
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(Matthews et a I . ,  2000). Additionally, stimulation of GABA-A receptors is 
protective against neuronal injury induced via NMDA receptor activity. GABA-A 
agonists block NMDA-induced damage and this protection can be reversed by 
GABA-A antagonists (Ohkuma et aI . ,  1 994). Therefore, the evidence indicates 
that there is an important relationship between NMDA receptor-mediated 
excitation and GABA-A receptor-mediated inhibition . Interactions between NMDA 
and GABA-A receptors following injury may be time dependent. During the more 
acute stage of neuroexcitation, GABA-A receptor expression may be reduced. 
Chronic hypo-excitation during the chronic phase, however, would ind icate that 
the inhibitory system is strengthened over time. This strengthening of cortical 
input into the DG of the hippocampus was demonstrated by Reeves et al. in 
1 997. GABA-A receptor alterations may, therefore, be an essential ,  yet 
uncharacterized, component to the maintenance of the neuronal balance 
between excitation and inhibition both acutely and chronically following TBI .  
The most abundant subunits i n  the brain include the 0 1 , 02, P2, P3, and 
y2 subunits (Stephenson,  1 995). Of the 0 subunits, 01 tends to co-localize with 
P2 and y2 on interneurons in the hippocampus, while 02 tends to co-localize with 
P3 and y2 on principal neurons such as pyramidal cells and DG granule cells. 
Whereas GABA-A receptor subunits on principal hippocampal neurons are 
regulated by Ca2+-related phosphorylation factors (e.g . ,  CaM kinase " 
phosphorylation and calcineurin dephosphorylation) ,  there is some evidence to 
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indicate that interneurons i n  the hippocampus may be governed by non-Ca2+­
mediated cascades (Sik, Hajos, Gulacsi, Mody, & Freund , 1 998) . These 
differences may be due to receptor composition. Principal cells (pyramidal and 
granule) tend to express GABA-A receptors containing 133 subunits, which 
contain an additional intracellular serine residue for phosphorylation (Brandon et 
a I . ,  2000; McDonald et aI . ,  1 998) and have the unique ability to transcytose, 
provid ing a mechanism for receptor isoform relocation (Connoilly et aI . , 1 996). 
Therefore, it is important to distinguish between interneurons and principal 
neurons when exploring GABA-A receptor alterations following TBI.  
The a 1 subunits, which are found primarily on interneurons in the 
hippocampus, have been shown to be altered following ischemic injury 
(Inglefield , Wilson, & Schwartz-Bloom, 1 997; Li, Siegel, & Schwartz, 1 993) and 
BZ tolerance studies (Pesold et a I . ,  1 997). Additionally, 132/3 subunits have been 
shown to have regional alterations in the hippocampus 24 hours following central 
FPI (Gibson, 2000), although this study did not d istinguish between 132 and 133 
subunits. 
Summary 
TBI-induced depolarization results in Ca2+ influx through both NMDA­
gated and voltage-gated ion channels. NMDA receptor-mediated Ca2+ influx is 
well documented and clearly a critical contributor to excessive intracellular free 
Ca2+ levels (Thomas et aI . ,  1 990; Fineman et a I . ,  1 993). Elevated [Ca2+1 may 
72 
alter gene expression at both the transcriptional and translational levels (Bading 
et a I . ,  1 995; Barish, 1 998), and/or may trigger an enzymatically-driven 
intracellular cascade that results in the dephosphorylation of GABA-A receptor 
subunits (Morioka et a I . ,  1 990). Alterations to the GABA-A receptor have yet to 
be characterized following TBI ,  although they are well documented following 
ischemia ( Ing lefield, Wilson ,  & Schwartz-Bloom, 1 997; Johansen & Diemer, 
1 991 ; Schwartz-Bloom et a I . ,  1 998). 
The a subunits play important modulatory roles in GABA-A receptor 
binding properties and a 1  mRNA (Li, Siegel, & Schwartz, 1 993) and protein 
expression ( Inglefield , Wilson, & Schwartz-Bloom, 1 997) are decreased following 
ischemic injury. Additionally, a 1  is most abundant in the hippocampus on 
interneurons (Mohler et a I . ,  1 996), providing an indication of how GABA-A 
receptor expression in interneurons is altered following TBI .  
The � subunits contain the GABA binding site and are found in nearly al l  
GABA-A receptors (Huh et a I . ,  1 995, 1 996 ; Stephenson, 1 995). Their importance 
is further highlighted by their implication in phosphorylation factors, a qual ity they 
share with y2 subunits. The �3 subunit is abundant in the hippocampus and it 
tends to localize in GABA-A receptors on principal neurons such as pyramidal 
cells and DG granule cells (Barnard et al. , 1 998; Mohler et aI . ,  1 996) . Alterations 
to �3 subunits, therefore, may be an indication of changes occurring primarily to 
receptors located on principal neurons. In TBI .  preliminary evidence (Gibson. 
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2000) indicates that the expression of P2/3 subunits of the GABA-A receptor is 
decreased 24 hours following injury. Alterations to the structure of the GABA-A 
receptor may be associated with functional consequences such as decreased CI­
conductance and consequent reductions in cellular hyperpolarization. Disrupted 
homeostasis mediated by dysfunctional GABA-A receptors may, therefore, 
contribute to excessive neuroexcitation and subsequent dysfunction following 
TBI .  
The current overall hypothesis is that TBI induces: 1)  a well-documented 
massive Ca2+ influx, which 2) triggers intracellular calcium-mediated mechanisms 
that 3) alter the structural expression of the GABA-A receptor and 4) result in 
receptor dysfunction. The primary focus of the current research project involves 
the first (Ca2+) and third (GABA-A receptor) steps in the above cascade (see 
Figure 5 for a summary) . First, Study 1 characterized changes to the a 1 and p3 
GABA-A receptor subunits in the hippocampus following central FPI  in rats and 
examined the time course of these changes. Then, Study 2 used 
pharmacological intervention (MK-B0 1 )  to normalize GABA-A receptors by 
preventing the NMDA-mediated Ca2+ cascade that contributes to excessive 
neuroexcitation and neuronal dysfunction. 
Methods 
Subjects 
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Figure 5. The potential cascade of events involving GABA-A receptors following 
TBI .  The steps addressed are highlighted in red . 
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Adult male Sprague-Dawley rats weighing approximately 320-340g were 
used for all experiments. Animals were housed individually in a vivarium in 
shoebox-type cages on a 1 2: 1 2  hour light/dark cycle and received food and 
water ad libitum. The general health and weight of the animals was monitored 
daily and the general care was maintained by university staff veterinarians. 
Surgical Preparation 
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All surgical preparations were performed with sterile instruments under 
antiseptic conditions. Subjects were surgically prepared under sodium 
pentobarbital (54 mg/kg) ,  24 hours prior to injury. While under anesthesia, 
animals were placed in a stereotaxic frame and a sagittal incision was applied to 
the scalp. A craniotomy hole was made over the central suture, midway between 
bregma and lambda. Burr holes were drilled to hold two nickel plated screws (2-
56 x 6 mm) 1 mm rostral to bregma and 1 mm caudal to lambda along the 
central suture. A modified Leur-Loc syringe hub (2.6 mm interior diameter) was 
placed over the exposed dura and sealed with cyanoacrylate adhesive. Dental 
acrylic was applied over the entire device (leaving the hub accessible) to secure 
the hub to the skul l .  The incision was sutured and bacitracin applied to the 
wound. Animals were kept warm and continuously monitored until they had fully 
recovered from the anesthesia. Upon recovery, animals were returned to the 
vivarium where food and water were available ad libitum.  
Central Fluid Percussion Injury 
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Although there are no rat models of TBI that effectively replicate all 
features of human head injury, the central fluid percussion model has been 
shown to produce a diffuse injury that reliably depicts many important aspects of 
human TBI .  
Injury Device 
The fluid percussion injury device has been described in detail elsewhere 
(Dixon et aI . , 1 987; Mcintosh et a I . ,  1 987). Briefly, the injury device consists of a 
Plexiglass cylinder 60 cm long and 4.5 cm in diameter, which is filled with saline. 
A rubber-covered piston at one end of the device is mounted on O-rings. On the 
other end , metal housing contains a pressure transducer (Entran Devices, Inc. , 
model EPN-0300*-1 00A). A 5-mm syringe with an interior diameter of 2 .6  mm 
terminates in a male Leur-Loc fitting, which is located on the end of the pressure 
transducer. The male fitting is connected to the modified female Leur-Loc hub 
implanted over the open dura of the rat. A metal pendulum (4 .54 kg) is released 
from a pre-determined elevation , impacting the piston of the injury device. The 
impact del ivers a pressure pulse through the continuous water-fi lled cylinder into 
the closed cranium of the rat. Brief displacement and deformation of brain tissue 
results and the pressure pulse is measured by the pressure transducer in 
atmospheres (atm) and displayed on a storage oscilloscope (Tektronix 51 1 1 :  
Beaerton, OR). 
I njury Procedure 
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Animals were anesthetized under 4% isoflurane in a carrier gas consisting 
of 70% N20 and 30% °2, twenty-four hours following surgical preparation. The 
surgical incision was re-opened and the animals were connected to the fluid 
percussion device via the female-to-male connection described above. Animals 
in the injury groups received a moderate fluid pulse (2. 1  ± . 1  atm) .  Sham animals 
were attached to the injury device but no fluid pulse was delivered . The incision 
was sutured and bacitracin applied. Neurological assessments including tail, 
cornea, and righting reflexes were evaluated. The animals were closely 
monitored until they had sufficiently recovered and were then transferred back to 
the vivarium where food and water was available ad libitum.  
Brain Tissue Preparation 
Animals were anesthetized under 4% isoflurane in a carrier gas consisting 
of 70% NP and 30% O2 at the time point indicated by the study design .  The rats 
were quickly decapitated and bilateral h ippocampi were dissected away on ice. 
The hippocampi were weighed and homogenized with a motorized homogenizer 
in a buffer consisting of 3ml R IPA lysis buffer (US Biological) and 30 1-11 Complete 
cocktail protease inhibitor (Roche Molecular Biochemicals) per gram of tissue. 
Study 1 :  Western Blot Analysis of TBI-Induced Alterations to GABA-A Receptor 
Subunits 01 and 83 at 3 hours, 24 hours, and 7 days Post-Injury 
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Western Blot analyses of TBI-induced alterations to the GABA-A receptor 
subunits 0 1  and �3 in the hippocampus at several post-injury time points (3 hr, 
24 hr, and 7 days) were conducted. 
Design and Analysis 
The experimental design was a 2 (TBI or sham) x 3 (time) factorial .  Tissue 
obtained from each animal was used to analyze both 0 1  and �3 subunit 
expression. Due to gel size constraints, density measurements had to be pooled 
across several blots. In order to control between-gel variance (e.g . ,  differences in 
staining intensity), data were normalized. The mean sham density for each gel 
was adjusted to represent 1 00%. The percent difference of each individual 
protein density was then calculated against the sham mean. Once normalized , 
data were pooled across gels. Results from each subunit were analyzed 
separately by an ANOVA (Group x Time). In order to determine which time point 
produced the greatest change, a Fisher's LSD post-hoc was used to analyze 
pairwise comparisons for each time point. 
Western Blot Procedure 
The Western Blot procedure was adapted from Santa Cruz 
Biotechnology, Inc. All materials (e.g . ,  gels, buffers) were Invitrogen's NuPage 
products, unless otherwise specified . Following homogenization, bilateral 
hippocampi were centrifuged at 1 0,000 xg for 1 0  minutes. The supernatant was 
removed and spun a second time at 1 0,000 xg for 1 0  minutes. Aliquots of 1 0  u l  
of lysate (the supernatant) were stored at -20°C until they were used. 
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A Bio-rad micro assay was used to assess the amount of protein in each 
sample by using a standard regression equation to calculate the amount of 
protein from the spectrophotometer readings of optical density. Each lane of the 
gel contained a standard amount of sample buffer (6 .3  �I)  and reducing agent 
(2 .5  �I) .  The amount of water added was adjusted to ensure that equal amounts 
of protein were loaded in each lane ( 1 0  �g protein/ lane, determined empirically). 
Samples were heated at 70°C for 1 0  minutes. 
All treatment groups were run concurrently. Proteins were separated on a 
4-1 2% Bis-Tris mini-gel using a MOPS running buffer in the Novex Mini-Cell 
electrophoresis system. Separated proteins were then transferred to a 
nitrocellulose membrane ( Invitrogen; 90 min at 30V) . Standard weights were run 
alongside each condition, includ ing the negative controls. Negative controls 
included a lane that received all treatments, except no primary antibody was 
appl ied to the membrane. Additionally, control immunoglobulin ( lgG) (Santa 
Cruz) was run from the same species in which the primary antibody was raised. 
Following transfer, the gel was stained with Coomassie Blue to verify complete 
transfer to the membrane. The membrane was rinsed twice in TBS (25mM Tris­
base, 1 40 mM NaCI, 3mM KCI, pH 7.6), enclosed in plastic and stored at -20°C 
until immunoblotted . 
8 1  
Non-specific binding was blocked by Blotto A (5% milk i n  Tris with 0 .05% 
Tween 20; Santa Cruz) for 1 hr at room temperature (RT). The blot was then 
probed with GABA-A receptor anti-peptide 0 1  ( 1 : 1 00) or anti-peptide [33 (1 :75) 
(Santa Cruz) d iluted in Blotto A for 1 hr at RT. Primary antibody concentrations 
were empirically determined. The membranes were washed 4 x 1 5  minutes in 
TBS containing 0 .05% Tween 20 (TBST). Blots were then incubated for 1 hour at 
RT in horseradish peroxidase-conjugated donkey anti-goat secondary antibodies 
(1 :2000). Secondary antibody concentrations were empirically determined. Blots 
were then washed 4 x 1 5  minutes in TBST and 1 x 1 5  minutes in TBS. Specific 
peptide labeling was detected by chemiluminescent luminol reagent (Santa 
Cruz). The luminol reagent was applied to the blot for 1 minute. Following 
development, the blot was drained and exposed to BioMax x-ray film for 
visualization. Several exposure times, ranging from 1 5  sec to 5 minutes were 
tested to determine the clearest visual ization. Densitometry was used to 
measure the optical density of the bands corresponding to the appropriate 
molecular weight for each subunit (Scion Image for Windows, Scion 
Corporation) .  Following immunoblotting, membranes were stained with BLOT­
FastStain (Geno Technology, Inc.) to ensure there was even loading of proteins 
across lanes. 
Study 2 :  Pharmacological Blockade of TBI-Induced NMDA-Mediated Calcium 
Influx and its Effect on the GABA-A Receptor 0 1  Subunit at 24 hours Post-Injury. 
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Design and analysis 
Study 2 was designed to manipulate the injury cascade at the time point 
of greatest change. A one factor ANOVA was used to compare 4 groups (injured , 
sham, injured-treated, and sham-treated) 24h following TBI (time point 
determined by Study 1 ) . Drug injections (MK-80 1 ,  0.3 mg/kg) were given 1 5  
minutes prior to FPI in order to block NMDA-mediated Ca2+ influx. All drug 
treatment groups were then run concurrently with sham and injured groups 
during Western Blot procedures to control for variation in group effects. 
Drug Administration 
NMDA-mediated Ca2+ influx was blocked by 0 .3  mg/kg/mL MK-801 
(Research Biochemicals International), in saline solution. This dose was 
previously shown to be protective against motor deficits (Hayes, Jenkins & Lyeth, 
1 992b) and cognitive deficits following TBI alone (Hamm, O'Dell , Pike, & Lyeth, 
1 993) or in combination with secondary bilateral entorhinal cortex lesions 
(Phil l ips, Lyeth, Hamm , Reeves, & Povlishock, 1 998). 
Results 
Experimental Controls 
No protein bands were visible on any blots run under minus primary 
conditions (see Figure 6). Several blots included a negative control lgG from the 
same species as the primary antibody. Immunoblotting did not produce any 
noticeable staining of the control IgG condition (see Figure 6). 
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Following transfer of the proteins to the membrane, all gels were stained 
with Coomassie blue to ensure uniform transfer. Protein transfer was equivalent 
across lanes, if not always complete (See Figure 7). Following immunoblotting 
and analysis, the membrane was stained to confirm an even distribution of 
protein across lanes. Protein transfers were found to be evenly distributed across 
all lanes (see Figure 8) . Any blots revealing uneven distribution of protein were 
excluded from the studies. 
Study 1 :  Western Blot Analysis of TBI-Induced Alterations to GABA-A Receptor 
Subunits 01 and 83 at 3 hours, 24 hours, and 7 days Post-Injury 
GABA-A Receptor 83 Subunit 
Post-Injury Reflexes 
A 2 x 2 ANOVA (group: sham and injured x time: 3h and 24h) indicated 
that injury significantly suppressed reflexes. All reflexes were measured in 
minutes. Tail pinch, was suppressed in the injured group (M = 3.57) compared to 
the sham group (M = 1 .0),  F ( 1 . 1 3) = 7.581 , P < .05. Corneal reflex was also 
suppressed in the injured group (M = 6.20) compared to the sham group (M = 
1 .0) ,  F (1 . 1 3) = 8.688,  P < .05.  Tail pinch and corneal response are simple 
reflexes. The more complex righting reflex was delayed following injury (M = 
7 .88), compared to the sham animals (M = 2 .00) ,  F ( 1 . 1 3) = 1 5.707, P < .05. There 
were no differences on any measure for the variable time, indicating that 
equivalent injuries were included in both time points (3 and 24 hours). 
Western Blot Protein Density Analysis 
A band recognized by the 133 antibody co-migrated with the 51 -kDa 
molecular weight standard .  A 2 x 2 ANOVA (group x time) did not reveal a 
significant injury effect (F ( 1 . 1 3) = 0.003, p >  .05) on 133 protein density. 
Additionally, there was not a significant effect of time (F ( 1 . 1 3) = 0 . 1 25,  P > .05). 
Although only the 3 hour and 24 hour time points were included in the analysis, 
analysis of the 133 subunit was terminated due to clear evidence that no injury­
induced changes were occurring by 24 hours (see Figures 9 and 1 0) .  
GABA-A Receptor a 1 Subunit 
Post-Injury Reflexes 
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A 2 x 3 ANOVA (group x time) indicated that injury Significantly 
suppressed reflexes (all reflex recovery was measured in minutes). Tail pinch 
was suppressed in the injured group (M = 3.44) compared to the sham group (M 
= 1 .0), F ( 1 . 27) = 20 . 1 83, P < .05. Corneal reflex was also suppressed in the 
injured group (M = 5.70) compared to the sham group (M = 1 .0) ,  F ( 1 . 27) = 57.291 , 
P < .05. The righting reflex was delayed following injury (M = 7.54) compared to 
the sham animals (M = 2.00), F ( 1 , 27) = 1 1 3. 1 87, P < .05. There were no 
differences on any measure for the variable time, indicating that equivalent 
injuries were included in all time points (3 hours, 24 hours, and 7 days). 
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Mortality 
Mortality rates for animals in each group are shown in Table 4. A Chi­
Square test of independence revealed a significant difference in mortality 
between groups, X2 ( 1 . t:!.: 54) = 1 5.789, P < .05.  There also was a significant effect 
of time, X2 (2. t:!.: 54) = 5.959, P = .05 ,  with the 24 hour time point having higher 
mortality (56%) than all other groups (20% at 3 hours and 29% at 7 days). The 
primary cause of mortal ity for all groups was pulmonary edema, which occurred 
with in the first 5 minutes following injury. Although mortality was higher in the 24 
hour injured group, the surviving animals had equ ivalent injury characteristics 
(severity and reflex recovery) with the other time points. 
Western Blot Protein Density Analysis 
A clear band at approximately 48-kDa was recognized by the a 1  antibody. 
A 2 x 3 ANOVA (group x time) revealed a sign ificant effect of injury on a 1  protein 
density, F ( 1 27) = 2 1 .503, P < .001 . Injured animals (M = 1 26 .36) had significantly 
denser GABA-A receptor a 1  subunit protein than sham animals (M = 1 00.54). 
The main effect of time approached Significance (F (2. 27) = 3.043, P = .06), and no 
interaction was found (F (2. 27) = 2.61 3,  P > .05). In order to determine at which 
time point injury had the greatest effect on protein density, a Fisher LSD post­
hoc was used to analyze differences between groups. Due to unequal group 
sizes, a harmonic sample mean was used for all analyses. The Fisher LSD 
revealed that injured animals had significantly higher protein densities at 24 
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hours (M = 1 4 1 . 1 5) and 7 days (M = 1 32 . 1 7) compared to 3 hours (M = 1 09 . 1 8) 
post-injury (see Figures 1 1  and 1 2) .  No other significant differences were found . 
Study 2 :  Pharmacological Blockade of TBI-Induced NMDA-Mediated Calcium 
Influx and its Effect on the GABA-A Receptor 0 1  Subunit at 24 hours Post-Injury. 
Post-Injury Reflexes 
A one factor ANOVA (group: sham, injured , sham-treated, and injured­
treated) revealed that the tail pinch reflex was significantly suppressed in injured 
animals (M = 3.65), as compared to sham (M = 1 .00), sham-treated (M = 1 .00), 
and injured-treated (M = 1 .55) groups, F (3, 1 7) = 6.931 , P < .05. The corneal reflex 
was also suppressed in injured animals (M = 6.01 ) ,  compared to sham (M = 
1 .00), sham-treated (M = 1 .00), and injured-treated (M = 3.49) groups, F (3 17) = 
1 3.952, P < .05.  The pre-injury injections of MK-801 may have normalized the 
suppression of simple reflexes (tail pinch and cornea) in the injured-treated 
group, but this effect was not present for the more complex righting reflex. 
Analysis of the righting reflex revealed that it was significantly suppressed in both 
injured (M = 8.48) and injured-treated (M = 6.73) groups, as compared to sham 
(M = 2 . 00) and sham-treated (M = 2.00) groups, F (3. 1 7) = 31 .960, P < .05. 
Mortality 
Mortal ity rates for animals in each group are shown in Table 4. A Chi­
Square test of homogeneity revealed a significant difference in mortality between 
groups, X2 (3. ti,= 39) = 1 5.234 , P < .05. The sham and sham-treated groups had 
0% mortality, whereas the injured (74%) and injured-treated (44%) groups had 
relatively high death rates (see Table 5). The primary cause of mortality in 
injured animals was pu lmonary edema. 
Western Blot Protein Density Analysis 
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As determined by study 1 ,  the 24 hour post-injury time point revealed the 
greatest increase in 0 1  protein. Therefore, the effects of MK-801 treatment in 
study 2 were analyzed 24 hours following injury. A one factor ANOVA revealed 
significant group differences in protein density for the 0 1  subunit of the GABA-A 
receptor, F (3. 1 7) = 1 6.455, P < .001 . A Fisher LSD post-hoc revealed that the 
injured group (M = 1 4 1 . 1 5) had sign ificantly denser protein than sham (M = 
1 01 .52), sham-treated (M = 80.77) and injured-treated (M = 79. 1 3) groups (see 
Figures 1 3  and 1 4) .  No other significant differences were found. 
Figure 6. Representative photographs of Western blot negative controls. 
Respectively from top to bottom, the straight black lines represent standard 
weights 1 91 ,  64 , 51 , 39, 28, 1 9 , and 1 4  kDa. 
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Figure 7. A representative gel stained with Coomassie Blue following transfer of 
proteins to the membrane. 
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Figure 8.  A representative example of the protein distribution on the membrane. 
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Figure 9.  The mean percent density (and S.E.M.)  of GABA-A receptor f33 subunit 
protein in the hippocampus for Study 1 .  No significant injury or time effects were 
found . 
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Figure 1 0 . A representative photograph of Western blot analysis for GABA-A 
receptor 133 subunits at 24 hours post-injury in Study 1 .  
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Table 4. The mortality percentages per group for Study 1 .  A chi-square test of 
independence was sign ificant. X2 ( 1 )  = 1 5.789. P < .05.  
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Figure 1 1 .  The mean percent density (and S .E.M. )  of GABA-A receptor a 1  
subunit protein i n  the hippocampus for Study 1 .  TBI significantly increased 
protein density compared to sham, F ( 1 . 27) = 2 1 .503, P < .00 1 .  
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Figure 1 2 . A representative photograph of Western blot analysis for GABA-A 
receptor a 1 subunits at 24 hours post-injury in Study 1 .  
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Table 5. The mortality percentages per group for Study 2 .  A chi-square test of 
independence was significant, X2 (3) = 1 5.234, P < .05. 
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Figure 1 3. The mean percent density (and S.E .M. )  of GABA-A receptor a 1  
subunit protein in the hippocampus for Study 2 .  The NMDA anatagonist MK-801 
normalized TBI-induced increases in protein density, F (3. 1 7) = 1 6.455, P < .001 . 
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Figure 14 .  A representative photograph of Western blot analysis for GABA-A 
receptor a 1  subunits24 hours post-injury in Study 2 .  
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Discussion 
Study 1 showed that the GABA-A receptor subunits 01 and 133 change 
differentially due to TBI .  The 133 subunit was not altered significantly by injury at 
either 3 or 24 hours.  The 0 1  protein, however, was enhanced by 24 hours and 
this increase persisted for at least 7 days. The differential effects of injury on 
various subunits may be related to the differential distribution and function of 
specific receptor subtypes. I n  the hippocampus, the 133 subunit tends to co­
local ize with 02 and y2 on principal neurons (i .e. , pyramidal and granule cells), 
which are primarily excitatory neurons. The 0 1  subunit, however, tends to co­
local ize with 132 and y2 on inhibitory interneurons (Barnard et a I . ,  1 998; Mohler et 
a I . ,  1 996 ; Sperk et a I . ,  1 998). A single interneuron in the hippocampus may 
ultimately influence thousands of post-synaptic principal cells. Interneurons in the 
DG maintain membrane depolarization in response to perforant pathway 
stimulation. This long-term depolarization allows interneurons to produce action 
potentials to previously subthreshold excitatory potentials, providing an inhibitory 
regulatory mechanism that is unique to the hippocampus (Ross & Soltesz, 200 1 ) .  
I ncreases i n  0 1  and 13 2  i n  the cerebellum and cortex early i n  development 
(9 weeks) translate into increased inhibitory tone and delay the onset of 
isoniazid- induced seizures (Follesa et a I . ,  1 999). GABA-A mRNA changes 
precede receptor expression and functional alterations that drive epileptogenesis 
(Brooks-Kayal et aI . , 1 998). In the hippocampus, reduced inhibitory tone in 
I I I  
seizure-prone animals i s  associated with reduced a 1  mRNA and protein 
expression (Poulter et al . . 1 999). Increased inhibitory tone due to increases in 
interneuronal subunits (a 1 & (32) is consistent with the chronic phase of TBI. 
which is characterized by a suppression in neuronal activity. It should be noted . 
however. that an increase in inhibitory tone on interneurons would reduce 
depolarization. Since interneurons in the hippocampus provide inhibitory 
regulation of excitabil ity in principal cells. a reduction in GABA release from 
interneurons may produce a net increase in excitation. 
In  the rat. the chronic phase of neuronal hypofunctioning begins around 
24 hours (Hubschmann .  1 985). In the current study. increases in a 1  protein were 
found at 24 hours and 7 days. but were not present during the acute phase (3 
hours post-injury). Therefore. the acute phase of neuronal over-excitation may 
trigger a strengthening of interneuronal inhibitory tone in the hippocampus. and 
increased a 1 protein expression may be an important contributor to the neuronal 
dysfunction that occurs chronically following TBI .  
I ncreases in interneuronal inhibitory tone and corresponding increases in 
interneuronal subunits may involve a shift in GABA-A receptor subunit 
expression. similar to the shift that occurs during development. Both in vitro and 
in vivo studies have shown a compensatory shift in subunit expression in 
hippocampal neurons during development. Relative expression of a2. a3. and 
a5 are highly expressed in embryonic neurons (Poulter et al . 1 999). Postnatally. 
1 1 2 
0 1 ,  �2, and y2 subunit mRNAs increase two- to five- fold during the first two 
weeks (8rooks-Kayal ,  J in ,  Price, & Dichter, 1 998; 8rooks-Kayal et a I . ,  2001 ) .  
Miniature inhibitory post-synaptic currents ( IPSCs) in cerebellar neurons on post­
natal day 35 (P35) demonstrate significantly slower decay rates in 0 1  subunit­
deficient mice,  compared to wild-type mice, indicating that increased 0 1 -
containing subunit assembly may be responsible for fast inhibitory synaptic 
currents (Vicini et a I . ,  2001 ) .  In the hippocampus, DG interneurons exhibit 
calcium-dependent long-term depolarization after high-frequency perforant 
pathway stimulation (Ross & Soltesz, 2001 ) .  GA8A-A receptor subunit mRNA 
and protein expression in the DG and subsequent subunit shifts and receptor 
subtype changes during postnatal development are correlated to functional 
alterations. I ncreases in specific subunits (including 0 1 )  translate into increases 
in receptor blockade by zinc ions and reduced receptor augmentation by both 
positive and negative 8Z modulators (8rooks-Kayal et a I . ,  200 1 ) . Therefore, 
developmental shifts that increase interneuronal GA8A-A receptor subunit 
expression may have functional consequences that include changes in receptor 
ligand modulation and increases in inhibitory tone. 
Not only can GA8A-A subunit concentration alter ligand activity, but 
chronic ligand exposure may, in turn , alter receptor subunit expression . Chronic 
GA8A exposure may alter binding of transcriptional factors, which may alter 
GA8A-A receptor subunit composition and expression. Persistent exposure of in 
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vitro neurons to GABA decreases 0 1  and 131 mRNA and subsequent protein 
expression (Lyons, Gibbs, & Farb, 2000; Russek, Bandyopadhyay, & Farb, 
2000). Changes to the 131 subunit mRNA occur at the transcriptional level, by an 
alteration in the binding of a sequence-specific transcription factor ( 1m) to its 
initiator component (Russek, Bandyopadhyay, & Farb, 2000). GABA- induced 
decreases in both 0 1  and 131 may be associated with their interactive functions. 
Cystein residues on 01 and 131 near the middle of M2 (the pore-l ining segment of 
the polypeptide chain) asymmetrically rotate and form a disulfide bond that locks 
the channel open in the presence of GABA (Horenstein et a I . ,  2001 ) .  Alterations 
of a single amino acid residue (leucine) in the g' position of the M2 region alters 
131 , but not 0 1 ,  conformation and function ,  ultimately reducing CI- currents 
(Dalziel et a I . ,  2000). Modifications of amino acid residues alter the 
conformational folding of the receptor, and may mask or unmask binding sites 
such as those for GABA. The GABA binding pocket is located in a narrowing 
cleft, which constricts during activation (Wagner & Czajkowski, 2001 ) .  Therefore, 
even subunits with similar functions may be altered differently by sol itary 
changes to a single amino acid in the polypeptide chain. 
Regulatory changes may differ among GABA-A receptor subunits. 
Although the current studies only addressed 0 1  and 133 subunits, other subunits 
may also change due to TBI .  Cultured cerebellar granule cells exposed to protein 
kinase A demonstrate a down-regulation of 06 and 133 mRNA and an up-
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regulation of a 1  and P2 mRNA. Changes occurred at both the transcriptional and 
translational levels. Protein kinase A inhibitors prevented these effects on a 1 but 
not on a6, indicating differential regulatory mechanisms for different subunits 
(Thompson et aI . , 2000). 
Epilepsy research also demonstrates disparate alterations in subunits. 
Although P3 mRNA decreases in the DG (6 hours), CA1 (progressive) , and CA3 
(24 hours) following kainic acid- induced seizures, a 1  mRNA increases in the 
interneurons of the DG and in the CA3 of the hippocampus. Protein expression, 
however, does not always reflect mRNA changes, although interneuronal (e.g . ,  
a 1 )  mRNA and protein may be selectively spared following seizures due to a 
compensatory strengthening of inhibitory tone (Sperk et aI . ,  1 998). 
There may also be diverse regulatory mechanisms involved in the 
interaction between NMDA receptors and GABA-A receptors. Chronic blockade 
of calcium influx through the NMDA receptor with MK-801 treatment reduces P3 
and increases P2 mRNA in the hippocampus. Protein expression of neither P2 
nor P3 is altered (Kim et a I . ,  2000). Chronic MK-801 treatment does not alter 
GABA-A a 1 or NMDA receptor subunit mRNA or protein expression in the 
hippocampus but GABA-A receptor-mediated CI- uptake is significantly 
decreased (Matthew et a I . ,  2000). Therefore, NMDA receptor ligand binding may 
result in disparate alterations to one or more GABA-A receptor subunits, and 
these changes may have specific functional consequences. 
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Disparate alterations to GABA-A 0 1  and �3 subunits indicate that 
interneuronal alterations may occur following TBI ,  and these changes may have 
important consequences. Interneurons receive GABAergic input from both local 
and distant circuitry. DG interneurons receive input from the EC, the septum, and 
the hilar region of the DG. Considering that each of these areas has been shown 
to be susceptible to TBI (H icks et aI . ,  1 993; Lewen et aI . , 1 999; Smith et a I . ,  
1 997), dysfunctional signal ing from damaged regions may contribute to 
interneuronal GABA-A subunit alterations in the hippocampal formation. Since 
the hilus is especially vulnerable to FPI ,  local circuitry may be essentially 
involved in GABA-A receptor changes. 
Cell loss in the DG hilar reg ion following lateral TBI has been correlated 
with memory deficits (H icks et aI . ,  1 993). Cholinergic systems in the 
hippocampus and septum,  areas related to memory formation ,  are also altered 
by TBI (Dixon et a I . ,  1 997; Gorman et aI . , 1 996; Pike & Hamm, 1 997). 
ConSidering the disruptive effects TBI has on excitatory systems (e.g . ,  
cholinergic and glutamatergic), the alterations to GABA-A receptor subunits may 
be a symptom of a pathology that affects hippocampal GABAergic circuitry. 
Therefore, GABA-A receptor 0 1  protein changes may be a reflection of aberrant 
GABAergic function due to injury. 
The 01 subunit not only contributes to GABA-A receptor interneuron 
composition and function, but also has distinct functions of its own. Mice with 0 1  
1 1 6 
subunit point-mutations of a single amino acid ( i .e. , His to Arg at the BZ binding 
site) are rendered BZ-insensitive. Studies with these "knock-in" mice 
demonstrate that the a 1  subunit is responsible for the sedative effects of BZs 
such as DZ, whereas the a2 subunit is responsible for the anxiolytic effects of 
BZs. Additionally, a 1  plays a critical role in the production of anxious reactions in 
novel environments, an important element in behavioral testing of animals 
(Rudolph, Crestani ,  & Mohler, 200 1 ;  Tobler, Kopp, Deboer, & Rudolph, 2001 ) .  
The mechanism(s) driving the changes in GABA-A receptor subunit 
protein expression may occur anywhere along the pathway from mRNA 
transcription to insertion of the finished protein into the cellular membrane. 
Transcriptional regulators (Barish, 1 998), each translational step (Barish , 1 998; 
Palfrey & Nairn, 1 995), protein fold ing, protein expression, and insertion of the 
finished protein into the cellular membrane are all regulated by [Ca2+]; (Barish , 
1 998). Elevated [Ca2+]; suppresses GABA-mediated CI- conductance by 
decreasing the affinity of the receptor for GABA ( Inoue, 1 986). Additionally, 
localized increases in [Ca2+]; fluctuations may suppress GABA-A mediated IPSCs 
(Pitler & Alger, 1 992). Calcium influxes through NMDA receptor channels, but not 
voltage-gated channels, produce a persistent dephosphorylation-dependent 
suppression of GABA-A receptor currents in CA 1 pyramidal cell bodies and 
apical dendrites (Stelzer & Shi ,  1 994) .  The largest increases in [Ca2+1i occur in 
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the apical dendritic shaft in CA 1 pyramidal cells, which primarily receive synaptic 
input from GABAergic interneurons (Papp et a I . ,  2000). 
Electrophysiology studies in TBI research demonstrate that injury alters 
GABA-A receptor function. Lateral FPI reduces paired-pulse depression strength 
in CA3 to CA 1 commissural input but inhibition is strengthened in DG and CA 1 
EC input (Reeves et a I . ,  1 997). Concordantly, basal [Ca2+]; is elevated in isolated 
hippocampal neurons one and six days after central FPI .  Following glutamate 
exposure, TBI neurons take significantly longer to return to basal [Ca2+]; , 
compared to shams (Sun et aI . ,  2001 ) .  
Study 2 used a single pre-injury injection of MK-801 to normalize GABA-A 
receptor subunit expression. The blockade of calcium influx through the NMDA 
receptor effectively attenuated GABA-A receptor 0 1  subunit increases 24 hours 
post-injury, ind icating that alterations to the 0 1  subunit were induced by injury­
related elevations in [Ca2+]; . Although this study was not deSigned to determine 
which calcium- related mechanism drove the alterations to the 0 1  receptor, we 
do know that elevated [Ca2+]; suppresses GABA-mediated CI- conductance, 
thereby reducing inhibition.  I ncreases in 01 subunits and potential increases in 
interneuronal inhibitory tone may play a role in dysfunctional excitatory! inhibitory 
homeostasis following injury. Blockade of NMDA-mediated elevations in [Ca2+]; 
may prevent interneuronal strengthening and subsequent changes in inhibitory 
tone. 
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Future studies to determine the mechanism responsible should include 
molecular assays such as RT-PCR to determine whether GABA-A receptor 
subunit mRNA is altered following TBI .  Immunohistochemical analysis combined 
with RT-PCR could indicate whether changes are occurring at the transcriptional 
and/or translational level(s}. Immunohistochemistry and autorad iography studies 
could be used to determine whether persistent alterations to subunits are, as 
suspected, located on interneurons in the hippocampus and if these changes are 
regionally specific. The use of several antibodies which bind to different regions 
of the a 1 receptor are recommended in order to determine if changes are 
occurring due to the masking or unmasking of particu lar binding sites. 
Additionally, specific enzyme assays (e.g . ,  CaM Kinase II and calciuneurin) and 
Western blot analysis of only membrane-bound subunits may help clarify 
whether changes are occurring during transport and membrane insertion of 
finished proteins. The functional consequences of TBI-induced alterations to 
GABA-A receptor subunits could also be explored by use of electrophysiology 
studies, CI- conductance assays, and genetically altered mouse studies. 
The current studies demonstrate that TBI induces an increase in GABA-A 
receptor a1 , but not �3, subunits at 24 hours and 7 days post-injury. The 
differential directions of the alterations may indicate a strengthening of 
interneurons in the hippocampus chronically following injury, although this 
remains to be definitively determined. Although an increase in inhibitory tone 
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during the acute phase of neuronal over-excitation would likely be beneficial ,  
increased inhibition during the chronic phase of neuronal hypofunctioning is likely 
to be detrimental .  Speculatively, the increases in GABA-A receptor a 1  protein 
expression found in these studies may represent a mechanism by which the 
inhibitory system in the hippocampus is strengthened. Although the 
strengthening of the inhibitory system may originate as an adaptive response to 
acute neurotoxicity, it may ultimately contribute to maladaptive hypofunctioning 
chronically following TBI .  The functional consequences of increased inhibitory 
tone may contribute to long-term changes in L TP and behavioral outcome 
mediated by the hippocampus. 
Fol lowing TBI, acutely administered NMDA receptor antagonists are 
beneficial to cogn itive recovery (Phi l l ips et a I . ,  1 997) . Likewise, GABA-A receptor 
agon ists have been shown to be beneficial to MWM performance (O'Dell et aI . , 
2000), ind icating that alterations to the GABA-A receptor may contribute to 
cognitive deficits and these behavioral changes may involve an important 
interaction between excitatory (NMDA) and inhibitory (GABA-A) receptors. 
The changes to a 1  were likely driven by an elevated [Ca2+];- induced 
mechanism, since the subunit was normalized when NMDA-mediated calcium 
influx was blocked by MK-801 prior to injury. Acute neuronal activity and the 
subsequent influx of intracellular calcium mediated by the NMDA receptor have 
been well- documented following TBI . Study 2 indicates that pharmacological 
blockade of the NMDA receptor is not only beneficial in reducing excitation 
acutely, but may also play a role in normalizing inhibitory function chronically. 
These studies, therefore, support the hypotheses that TBI alters the GABA-A 
receptor and that this alteration is driven by a calcium-mediated mechanism. 
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